Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

The Company had ~~57,782,998~~56,461,543 shares of common stock, $1.00 par value per share, outstanding as of August ~~6, 2019.~~4, 2020.

	Three Months Ended June 30						Nine Months Ended June 30						Three Months Ended June 30						Nine Months Ended June 30
	2019			2018			2019			2018			2020			2019			2020			2019
	(In millions, except per share amounts)												(In millions, except per share amounts)
Net sales and other operating revenues	$	845		$	854		$	2,510		$	2,392		$	518		$	845		$	1,955		$	2,510
Cost of sales		675			657			1,996			1,831			449			675			1,592			1,996
Gross profit		170			197			514			561			69			170			363			514
Selling and administrative expenses		65			74			208			223			52			65			230			208
Research and technical expenses		16			17			47			48			13			16			41			47
Specialty Fluids loss on sale and asset impairment (Note D)		8			—			28			—
Purification Solutions long-lived assets impairment (Note F)		—			—			—			162
Purification Solutions goodwill impairment (Note F)		—			—			—			92
Specialty Fluids loss on sale and asset impairment														—			8			1			28
Income (loss) from operations		81			106			231			36			4			81			91			231
Interest and dividend income		2			2			6			8			1			2			7			6
Interest expense		(14	)		(14	)		(43	)		(41	)		(13	)		(14	)		(41	)		(43	)
Other income (expense)		—			1			(6	)		13			(3	)		—			(6	)		(6	)
Income (loss) from continuing operations before income taxes and equity in earnings of affiliated companies		69			95			188			16
Income (loss) before income taxes and equity in earnings of affiliated companies														(11	)		69			51			188
(Provision) benefit for income taxes		(30	)		4			(43	)		(194	)		5			(30	)		(9	)		(43	)
Equity in earnings of affiliated companies, net of tax		1			—			1			2			1			1			2			1
Net income (loss)		40			99			146			(176	)		(5	)		40			44			146
Net income (loss) attributable to noncontrolling interests, net of tax		8			11			22			31			1			8			10			22
Net income (loss) attributable to Cabot Corporation	$	32		$	88		$	124		$	(207	)	$	(6	)	$	32		$	34		$	124

Weighted-average common shares outstanding:
Basic		58.2			61.8			59.1			61.8			56.5			58.2			56.7			59.1
Diluted		58.4			62.3			59.2			61.8			56.5			58.4			56.7			59.2

Earnings per common share:
Earnings (loss) per common share:
Basic	$	0.55		$	1.41		$	2.08		$	(3.36	)	$	(0.12	)	$	0.55		$	0.59		$	2.08
Diluted	$	0.55		$	1.40		$	2.08		$	(3.36	)	$	(0.12	)	$	0.55		$	0.59		$	2.08

Dividends per common share	$	0.35		$	0.33		$	1.01		$	0.96

The accompanying notes are an integral part of these consolidated financial statements.

	Three Months Ended June 30						Nine Months Ended June 30						Three Months Ended June 30						Nine Months Ended June 30
	2019			2018			2019			2018			2020			2019			2020			2019
	(In millions)												(In millions)
Net income (loss)	$	40		$	99		$	146		$	(176	)	$	(5	)	$	40		$	44		$	146
Other comprehensive income (loss), net of tax
Foreign currency translation adjustment, net of tax (provision) benefit of $—, $(2), $(3) and $2		1			(109	)		(15	)		(50	)
Unrealized holding gains (losses) arising during the period, net of tax (provision) benefit of $—, $—, $— and $—		—			(1	)		—			(1	)
Foreign currency translation adjustment, net of tax														31			1			(4	)		(15	)
Derivatives: net investment hedges
(Gains) losses reclassified to interest expense, net of tax provision (benefit) of $—, $1, $1 and $1		(1	)		(1	)		(3	)		(3	)
(Gains) losses excluded from effectiveness testing and amortized to interest expense, net of tax provision (benefit) of $1, $—, $— and $—		1			—			1			—
Pension and other postretirement benefit liability adjustments
Pension and other postretirement benefit liability adjustments arising during the period, net of tax		1			—			23			—
(Gains) losses reclassified to interest expense, net of tax														(1	)		(1	)		(3	)		(3	)
(Gains) losses excluded from effectiveness testing and amortized to interest expense, net of tax														—			1			1			1
Pension and other postretirement benefit liability adjustments, net of tax														1			1			2			23
Other comprehensive income (loss)		2			(111	)		6			(54	)		31			2			(4	)		6
Comprehensive income (loss)		42			(12	)		152			(230	)		26			42			40			152
Net income (loss) attributable to noncontrolling interests, net of tax		8			11			22			31			1			8			10			22
Foreign currency translation adjustment attributable to noncontrolling interests, net of tax		(2	)		(7	)		—			—			2			(2	)		2			—
Comprehensive income (loss) attributable to noncontrolling interests, net of tax		6			4			22			31			3			6			12			22
Comprehensive income (loss) attributable to Cabot Corporation	$	36		$	(16	)	$	130		$	(261	)	$	23		$	36		$	28		$	130

The accompanying notes are an integral part of these consolidated financial statements.

	June 30, 2019		September 30, 2018		June 30, 2020		September 30, 2019
	(In millions)				(In millions)
Current assets:
Cash and cash equivalents	$	147	$	175	$	162	$	169
Accounts and notes receivable, net of reserve for doubtful accounts of $4 and $7		611		637
Accounts and notes receivable, net of reserve for doubtful accounts of $2 and $3						362		530
Inventories:
Raw materials		125		129		88		107
Work in process		—		3
Finished goods		340		329		250		305
Other		53		50		55		54
Total inventories		518		511		393		466
Prepaid expenses and other current assets		59		63		66		45
Total current assets		1,335		1,386		983		1,210
Property, plant and equipment, net		1,336		1,296		1,412		1,348
Goodwill		92		93		130		90
Equity affiliates		39		52		36		39
Intangible assets, net		100		98		102		96
Assets held for rent		—		118
Deferred income taxes		146		134		181		163
Other assets		71		67		175		58
Total assets	$	3,119	$	3,244	$	3,019	$	3,004

The accompanying notes are an integral part of these consolidated financial statements.

	June 30, 2019			September 30, 2018			June 30, 2020			September 30, 2019
	(In millions, except share						(In millions, except share
	and per share amounts)						and per share amounts)
Current liabilities:
Short-term borrowings	$	84		$	249		$	13		$	33
Accounts payable and accrued liabilities		553			613			460			537
Income taxes payable		3			29			14			22
Current portion of long-term debt		5			35			7			7
Redeemable preferred stock		—			26
Total current liabilities		645			952			494			599
Long-term debt		1,017			719			1,164			1,024
Deferred income taxes		40			42			41			41
Other liabilities		191			252			277			206
Commitments and contingencies (Note I)
Commitments and contingencies (Note G)
Stockholders' equity:
Preferred stock:
Authorized: 2,000,000 shares of $1 par value		—			—			—			—
Issued and Outstanding: None and none
Issued and Outstanding: NaN and NaN
Common stock:
Authorized: 200,000,000 shares of $1 par value
Issued: 57,952,863 and 60,566,375 shares
Outstanding: 57,758,660 and 60,366,569 shares		58			61
Less cost of 194,203 and 199,806 shares of common treasury stock		(6	)		(7	)
Additional paid-in capital		—			—
Issued: 56,611,504 and 57,250,454 shares
Outstanding: 56,460,448 and 57,080,589 shares								57			57
Less cost of 151,056 and 169,865 shares of common treasury stock								(4	)		(5	)
Retained earnings		1,351			1,417			1,277			1,337
Accumulated other comprehensive income (loss)		(311	)		(317	)		(400	)		(391	)
Total Cabot Corporation stockholders' equity		1,092			1,154			930			998
Noncontrolling interests		134			125			113			136
Total stockholders' equity		1,226			1,279			1,043			1,134
Total liabilities and stockholders' equity	$	3,119		$	3,244		$	3,019		$	3,004

The accompanying notes are an integral part of these consolidated financial statements.

	Nine Months Ended June 30						Nine Months Ended June 30
	2019			2018			2020			2019
	(In millions)						(In millions)
Cash Flows from Operating Activities:
Net income (loss)	$	146		$	(176	)	$	44		$	146
Adjustments to reconcile net income (loss) to cash provided by operating activities:
Depreciation and amortization		110			117			117			110
Specialty Fluids loss on sale and asset impairment		28			—			—			28
Impairment of investment in equity affiliate		11			—			—			11
Long-lived assets impairment charge		—			162
Goodwill impairment charge		—			92
Deferred tax provision (benefit)		(20	)		131			(20	)		(20	)
Gain on sale of investments		—			(10	)
Employee benefit plan settlement		6			—			—			6
Gain on sale of land		—			(11	)
Equity in net income of affiliated companies		(1	)		(2	)
Equity in earnings of affiliated companies								(2	)		(1	)
Non-cash compensation		11			16			5			11
Other non-cash (income) expense		(2	)		14			4			(2	)
Cash dividends received from equity affiliates								1			2
Changes in assets and liabilities:
Accounts and notes receivable		6			(151	)		172			6
Inventories		(14	)		(77	)		74			(14	)
Prepaid expenses and other current assets		(1	)		(6	)
Prepaid expenses and other assets								(25	)		(1	)
Accounts payable and accrued liabilities		(65	)		40			(68	)		(65	)
Income taxes payable		(24	)		2			(10	)		(24	)
Other liabilities		(27	)		(6	)		(14	)		(27	)
Cash dividends received from equity affiliates		2			8
Cash provided (used) by operating activities		166			143			278			166

Cash Flows from Investing Activities:
Additions to property, plant and equipment		(155	)		(167	)		(162	)		(155	)
Proceeds from sale of business, net of cash held in escrow of $5 and $—		130			—
Cash paid for acquisition of business, net of cash acquired of $— and $1		(3	)		(64	)
Proceeds from sale of investments		—			11
Proceeds from sale of land		—			13
Change in assets held for rent		(8	)		(5	)
Proceeds from sale of business, net of cash held in escrow of $— and $5								—			130
Acquisitions of businesses, net of cash acquired of $1 and $—								(92	)		(3	)
Other		3			1			2			(5	)
Cash provided (used) by investing activities		(33	)		(211	)		(252	)		(33	)

Cash Flows from Financing Activities:
Borrowings under financing arrangements		29			—			—			29
Repayments under financing arrangements		(18	)		(1	)		—			(18	)
Increase in short-term borrowings, net		—			2
Proceeds from (repayments of) issuance of commercial paper, net		(176	)		303
Proceeds from long-term debt, net of issuance costs		344			—
Proceeds from issuance (repayments) of commercial paper, net								(20	)		(176	)
Proceeds from long-term debt								444			344
Repayments of long-term debt		(75	)		(251	)		(334	)		(75	)
Repayments of redeemable preferred stock		(25	)		—			—			(25	)
Purchases of common stock		(144	)		(59	)		(44	)		(144	)
Proceeds from sales of common stock		2			18			3			2
Cash dividends paid to noncontrolling interests		(23	)		(21	)		(26	)		(23	)
Cash dividends paid to common stockholders		(60	)		(60	)		(60	)		(60	)
Cash provided (used) by financing activities		(146	)		(69	)		(37	)		(146	)
Effects of exchange rate changes on cash		(15	)		(12	)		4			(15	)
Increase (decrease) in cash and cash equivalents		(28	)		(149	)		(7	)		(28	)
Cash and cash equivalents at beginning of period		175			280			169			175
Cash and cash equivalents at end of period	$	147		$	131		$	162		$	147

The accompanying notes are an integral part of these consolidated financial statements.

	Common Stock, Net of Treasury Stock						Additional Paid-in			Retained			Accumulated Other Comprehensive			Total Cabot Corporation Stockholders’			Noncontrolling			Total Stockholders’			Common Stock, Net of Treasury Stock					Additional Paid-in			Retained			Accumulated Other Comprehensive			Total Cabot Corporation Stockholders’			Noncontrolling			Total Stockholders’
	Shares			Cost			Capital			Earnings			Income (Loss)			Equity			Interests			Equity			Shares			Cost		Capital			Earnings			Income (Loss)			Equity			Interests			Equity
	(In millions, except share amounts)																								(In millions, except share amounts)
Balance at September 30, 2018		60,367		$	54		$	—		$	1,417		$	(317	)	$	1,154		$	125		$	1,279
Balance at September 30, 2019																										57,081		$	52	$	—		$	1,337		$	(391	)	$	998		$	136		$	1,134
Adoption of accounting standards																																		3			(3	)		—						—
Net income (loss)											69						69			8			77											41						41			5			46
Total other comprehensive income (loss)														(3	)		(3	)		—			(3	)													40			40			3			43
Cash dividends paid:
Common stock, $0.33 per share											(20	)					(20	)		—			(20	)
Common stock, $0.35 per share																																		(20	)					(20	)					(20	)
Cash dividends declared to noncontrolling interests																																											(19	)		(19	)
Issuance of stock under equity compensation plans		344			—			—									—						—			273			—		1									1						1
Amortization of share-based compensation								5									5						5								1									1						1
Purchase and retirement of common stock		(1,201	)		(1	)		(5	)		(56	)					(62	)					(62	)		(699	)		—		(2	)		(32	)					(34	)					(34	)
Balance at December 31, 2018		59,510			53			—			1,410			(320	)		1,143			133			1,276
Balance at December 31, 2019																										56,655			52		—			1,329			(354	)		1,027			125			1,152
Net income (loss)											23						23			6			29											(1	)					(1	)		4			3
Total other comprehensive income (loss)														5			5			2			7														(75	)		(75	)		(3	)		(78	)
Cash dividends paid:
Common stock, $0.35 per share																																		(20	)					(20	)					(20	)
Cash dividends declared to noncontrolling interests																				(13	)		(13	)																			(16	)		(16	)
Cash dividends paid:
Common stock, $0.33 per share											(20	)					(20	)					(20	)
Issuance of stock under equity compensation plans		41			1			—									1						1			30			—		2									2						2
Amortization of share-based compensation								2									2						2								2									2						2
Purchase and retirement of common stock		(1,101	)		(2	)		(2	)		(46	)					(50	)					(50	)		(241	)		—		(4	)		(6	)					(10	)					(10	)
Balance at March 31, 2019		58,450		$	52		$	—		$	1,367		$	(315	)	$	1,104		$	128		$	1,232
Balance at March 31, 2020																										56,444			52		—			1,302			(429	)		925			110			1,035
Net income (loss)											32						32			8			40											(6	)					(6	)		1			(5	)
Total other comprehensive income (loss)														4			4			(2	)		2														29			29			2			31
Cash dividends declared to noncontrolling interests																	—			—			—
Cash dividends paid:																	—			—			—
Common stock, $0.35 per share											(20	)					(20	)					(20	)										(20	)					(20	)					(20	)
Issuance of stock under equity compensation plans		56			—			—									—						—			18			1		(1	)								—						—
Amortization of share-based compensation								4									4						4								2									2						2
Purchase and retirement of common stock		(747	)		—			(4	)		(28	)					(32	)					(32	)		(2	)		—		(1	)		1						—						—
Balance at June 30, 2019		57,759		$	52		$	—		$	1,351		$	(311	)	$	1,092		$	134		$	1,226
Balance at June 30, 2020																										56,460		$	53	$	—		$	1,277		$	(400	)	$	930		$	113		$	1,043

The accompanying notes are an integral part of these consolidated financial statements.

	Common Stock, Net of Treasury Stock						Additional Paid-in			Retained			Accumulated Other Comprehensive			Total Cabot Corporation Stockholders’			Noncontrolling			Total Stockholders’			Common Stock, Net of Treasury Stock						Additional Paid-in			Retained			Accumulated Other Comprehensive			Total Cabot Corporation Stockholders’			Noncontrolling			Total Stockholders’
	Shares			Cost			Capital			Earnings			Income (Loss)			Equity			Interests			Equity			Shares			Cost			Capital			Earnings			Income (Loss)			Equity			Interests			Equity
	(In millions, except share amounts)																								(In millions, except share amounts)
Balance at September 30, 2017		61,884		$	56		$	—		$	1,707		$	(259	)	$	1,504		$	121		$	1,625
Net income (loss)											(122	)					(122	)		10			(112	)
Total other comprehensive income (loss)														(4	)		(4	)		3			(1	)
Cash dividends paid:
Common stock, $0.315 per share											(20	)					(20	)					(20	)
Cash dividends declared to noncontrolling interests																				(10	)		(10	)
Issuance of stock under equity compensation plans		178			—			—									—						—
Amortization of share-based compensation								6									6						6
Purchase and retirement of common stock		(265	)		—			(6	)		(10	)					(16	)					(16	)
Balance at December 31, 2017		61,797			56			—			1,555			(263	)		1,348			124			1,472
Net income (loss)											(173	)					(173	)		10			(163	)
Total other comprehensive income (loss)														54			54			4			58
Cash dividends paid:
Common stock, $0.315 per share											(19	)					(19	)					(19	)
Cash dividends declared to noncontrolling interests																				(11	)		(11	)
Issuance of stock under equity compensation plans		30			—			1									1						1
Amortization of share-based compensation								6									6						6
Purchase and retirement of common stock		(8	)		(1	)		(7	)		7						(1	)					(1	)
Balance at March 31, 2018		61,819		$	55		$	—		$	1,370		$	(209	)	$	1,216		$	127		$	1,343
Balance at September 30, 2018																										60,367		$	54		$	—		$	1,417		$	(317	)	$	1,154		$	125		$	1,279
Net income (loss)											88						88			11			99												69						69			8			77
Total other comprehensive income (loss)														(104	)		(104	)		(7	)		(111	)														(3	)		(3	)		—			(3	)
Cash dividends paid:
Common stock, $0.33 per share											(21	)					(21	)					(21	)											(20	)					(20	)					(20	)
Cash dividends declared to noncontrolling interests																				(1	)		(1	)
Issuance of stock under equity compensation plans		421			—			16									16						16			344			—			—									—						—
Amortization of share-based compensation								4									4						4									5									5						5
Purchase and retirement of common stock		(681	)		—			(20	)		(20	)					(40	)					(40	)		(1,201	)		(1	)		(5	)		(56	)					(62	)					(62	)
Balance at June 30, 2018		61,559		$	55		$	—		$	1,417		$	(313	)	$	1,159		$	130		$	1,289
Balance at December 31, 2018																										59,510			53			—			1,410			(320	)		1,143			133			1,276
Net income (loss)																																			23						23			6			29
Total other comprehensive income (loss)																																						5			5			2			7
Cash dividends paid:
Common stock, $0.33 per share																																			(20	)					(20	)					(20	)
Cash dividend declared to noncontrolling interests																																									—			(13	)		(13	)
Issuance of stock under equity compensation plans																										41			1			—									1						1
Amortization of share-based compensation																																2									2						2
Purchase and retirement of common stock																										(1,101	)		(2	)		(2	)		(46	)					(50	)					(50	)
Balance at March 31, 2019																										58,450			52			—			1,367			(315	)		1,104			128			1,232
Net income (loss)																																			32						32			8			40
Total other comprehensive income (loss)																																						4			4			(2	)		2
Cash dividends paid:
Common stock, $0.33 per share																																			(20	)					(20	)		—			(20	)
Issuance of stock under equity compensation plans																										56			—			—									—						—
Amortization of share-based compensation																																4									4						4
Purchase and retirement of common stock																										(747	)		—			(4	)		(28	)					(32	)					(32	)
Balance at June 30, 2019																										57,759		$	52		$	—		$	1,351		$	(311	)	$	1,092		$	134		$	1,226

The accompanying notes are an integral part of these consolidated financial statements.

The consolidated financial statements have been prepared in conformity with accounting policies generally accepted in the United States (“U.S.”) and include the accounts of Cabot Corporation (“Cabot” or the “Company”) and its wholly owned subsidiaries and majority-owned and controlled U.S. and non-U.S. subsidiaries. Additionally, Cabot considers consolidation of entities over which control is achieved through means other than voting rights. Intercompany transactions have been eliminated in consolidation.

The unaudited consolidated financial statements have been prepared in accordance with the requirements of Form 10-Q and consequently do not include all disclosures required by Form 10-K. Additional information may be obtained by referring to Cabot’s Annual Report on Form 10-K for its fiscal year ended September 30, ~~2018~~2019 (“~~2018~~2019 10-K”).

The financial information submitted herewith is unaudited and reflects all adjustments which are, in the opinion of management, necessary to provide a fair statement of the results for the interim periods ended June 30, ~~2019~~2020 and ~~2018.~~2019. All such adjustments are of a normal recurring nature. The results for interim periods are not necessarily indicative of the results to be expected for the fiscal year.

Effective October 1, ~~2018,~~2019, the Company adopted the ~~new revenue recognition standard that~~ ~~amended the pre-existing~~ accounting standard for ~~revenue recognition. The Company used a modified retrospective approach, which is~~leases issued by the Financial Accounting Standards Board (“FASB”) in February 2016.

~~Effective October~~C, effective April 1, ~~2018,~~2020, the Company ~~adopted the new pension standard that~~ ~~amended the requirements on the presentation~~acquired Shenzhen Sanshun Nano New Materials Co., Ltd (“SUSN”), a leading carbon nanotube producer. The results of ~~net periodic pension~~operations, and ~~postretirement benefit costs. The Company used a retrospective transition method to reclassify net periodic benefit cost, other than the service component, from Cost~~cash flows, of ~~sales, Selling and administrative expenses and Research and technical expenses to Other income (expense)~~SUSN are included in the ~~Consolidated Statements of Operations for the prior periods presented, which is discussed in further detail in Note B.~~

Effective October 1, 2018, the Company realigned its business reporting structure under the Performance Chemicals segment and now combines its specialty carbons, fumed metal oxides and aerogel product lines into the Performance Additives business, and its specialty compounds and inkjet product lines into the Formulated Solutions business. Prior period Performance Chemicals segment revenue results have been recast to reflect the realignment.

In January 2019, the Company entered into an agreement to sell its Specialty Fluids business to Sinomine (Hong Kong) Rare Metals Resources Co. Limited, a wholly owned subsidiary of Sinomine Resource Group Co., Ltd. (“Sinomine”). The sale of the Specialty Fluids business closed in June 2019 and does not meet the criteria to be reported as a discontinued operation. Therefore, prior periods’Company’s consolidated financial statements ~~and disclosures have not been recast. Refer to Note D for further details regarding~~from the ~~sale~~date of ~~the Specialty Fluids business.~~acquisition.

Cabot recognizes revenue when its customers obtain control of promised goods or services. The revenue recognized is the amount of consideration ~~which~~that the Company expects to receive in exchange for those goods or services. ~~Cabot derives the majority of its revenues from contracts for the sale of products from its Reinforcement Materials, Performance Chemicals and Purification Solutions segments.~~ The Company’s contracts with customers are generally for products only and do not include other performance obligations. Generally, Cabot considers purchase orders, which in some cases are governed by master supply agreements, to be contracts with customers. The transaction price as specified on the purchase order or sales contract is considered the standalone selling price for each distinct product. To determine the transaction price at the time when revenue is recognized, the Company evaluates whether the price is subject to adjustments, such as for returns, discounts or volume rebates, which are stated in the customer contract, to determine the net consideration to which the Company expects to be entitled. Revenue from product sales is recognized based on a point in time model when control of the product is transferred to the customer, which typically occurs upon shipment or delivery of the product to the customer and title, risk and rewards of ownership have passed to the customer. The Company has an immaterial amount of revenue that is recognized over time. Payment terms typically range from zero to ninety days.

Shipping and handling ~~activities that occur~~costs incurred after the transfer of control of a product to the customer are billed to ~~customers~~the customer and are recorded as sales revenue, as the Company considers these to be fulfillment costs. Shipping and handling costs are expensed in the

period incurred and included in Cost of sales within the Consolidated Statement of Operations. Taxes collected on sales to customers are excluded from the transaction price.

The Company generally provides a warranty that its products will substantially conform to the identified specifications. The Company’s liability typically is limited to either a credit equal to the purchase price or replacement of the non-conforming product. Returns under warranty have historically been immaterial.

Revenue in the Specialty Fluids segment arose primarily from the rental of cesium formate. This revenue was recognized throughout the rental period based on the contracted rental terms. Customers were also billed and revenue was recognized, typically at the end of the rental period, for cesium formate product that was not returned. The Company also generated revenues from cesium formate sold outside of the rental process and from the sale of fine cesium chemicals. This revenue was recognized when control of the product transferred to the customer, which was typically upon delivery of the product.

As permitted by the FASB’s revenue recognition standard, Revenue from Contracts with Customers, when the period of time between the transfer of control of the goods and the time the customer pays for the goods is one year or less, the Company does not consider there to be a significant financing component associated with the contract.

The Company records tangible and intangible assets acquired and liabilities assumed in business combinations under the acquisition method of accounting. Amounts paid for assets acquired and liabilities assumed in an acquisition are allocated to the assets ~~acquired~~ and liabilities ~~assumed~~ based on their fair values at the date of acquisition. The Company uses assumptions and estimates in determining the fair value of assets acquired and liabilities assumed in a business combination. The determination of the fair value of intangible assets requires the use of significant judgment with regard to assumptions used in the valuation model. The Company estimates the fair value of identifiable acquisition-related intangible assets principally based on projections of cash flows that will arise from these assets. The projected cash flows are discounted to determine the fair value of the assets at the dates of acquisition.

Definite-lived intangible assets, which are comprised of trademarks, customer relationships and developed technologies, are amortized over their estimated useful lives and are reviewed for impairment when indication of potential impairment exists, such as a significant reduction in cash flows associated with the assets.

Goodwill is comprised of the purchase price of business acquisitions in excess of the fair value assigned to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized, but is reviewed for impairment annually as of ~~May~~August 31, or when events or changes in the business environment indicate that the carrying value of the reporting unit may exceed its fair value. A reporting unit, for the purpose of the impairment test, is at or below the operating segment level, and constitutes a business for which discrete financial information is available and regularly reviewed by segment management. Reinforcement Materials, and the fumed metal oxides, specialty compounds and specialty ~~compounds~~carbons product lines within Performance Chemicals, which are considered separate reporting units, carry the Company’s goodwill balances as of June 30, ~~2019.~~2020.

For the purpose of the goodwill impairment test, the Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If an initial qualitative assessment identifies that it is more likely than not that the carrying value of a reporting unit exceeds its estimated fair value, an additional quantitative evaluation is performed. Alternatively, the Company may elect to proceed directly to the quantitative goodwill impairment test. If based on the quantitative evaluation the fair value of the reporting unit is less than its carrying amount, a goodwill impairment loss would result. The goodwill impairment loss would be the amount by which the carrying value of the reporting unit, including goodwill, exceeds its fair value, limited to the total amount of goodwill allocated to that reporting unit. The fair value of a reporting unit is based on discounted estimated future cash flows. The fair value is also benchmarked against a market approach using the guideline public ~~companies~~company method. The assumptions used to estimate fair value include management’s best estimates of future growth rates, operating cash flows, capital expenditures and discount rates over an estimate of the remaining operating period at the reporting unit level. Based on the Company’s most recent annual goodwill impairment test performed as of ~~May~~August 31, 2019, the fair values of the Reinforcement Materials, Fumed Metal Oxides and Specialty Compounds reporting units were substantially in excess of their carrying values.~~Refer to Note F for details on the Purification Solutions goodwill impairment test and the resulting impairment charge recorded in the second quarter of fiscal 2018.~~

The Company’s long-lived assets primarily include property, plant and equipment, intangible assets and long-term ~~investments and assets held for rent.~~investments. The carrying values of long-lived assets are reviewed for impairment whenever events or changes in business circumstances indicate that the carrying amount of an asset may not be recoverable.

To test for impairment of assets, the Company generally uses a probability-weighted estimate of the future undiscounted net cash flows of the assets over their remaining lives to determine if the value of the asset is recoverable. Long-lived assets are grouped with other assets and liabilities at the lowest level for which independent identifiable cash flows are determinable.

An asset impairment is recognized when the carrying value of the asset is not recoverable based on the analysis described above, in which case the asset is written down to its fair value. If the asset does not have a readily determinable fair value, a discounted cash flow model may be used to determine the fair value of the asset. In circumstances when an asset does not have separately identifiable cash flows, an impairment charge is recorded when the Company no longer intends to use the asset.Refer to Note F regarding the results of the recoverability test performed on the long-lived assets of the Purification Solutions segment and the resulting impairment charge recorded in the second quarter of fiscal 2018.

The Company continues to ~~pursue~~consider strategic options for its Purification Solutions business. Depending on the actions taken, there could be a negative impact on the fair value of the Purification Solutions reporting unit, which may lead to ~~further~~an impairment.

Property, plant and equipment are recorded at cost. Depreciation of property, plant and equipment is calculated using the straight-line method over the estimated useful lives of the related assets. The depreciable lives for buildings, machinery and equipment, and other fixed assets are between twenty and twenty-five years, ten and twenty-five years, and three and twenty-five years, respectively. The cost and accumulated depreciation for property, plant and equipment sold, retired, or otherwise disposed of are removed from the Consolidated Balance Sheets and resulting gains or losses are included in earnings in the Consolidated Statements of Operations. Expenditures for repairs and maintenance are charged to expenses as incurred. Expenditures for major renewals and betterments, which significantly extend the useful lives of existing plant and equipment, are capitalized and depreciated.

The Company records its tax provision or benefit on an interim basis using an estimated annual effective tax rate. This rate is applied to the current period ordinary income or loss to determine the income tax provision or benefit allocated to the interim period. Losses from jurisdictions for which no benefit can be recognized and the income tax effects of unusual or infrequent items are excluded from the estimated annual effective tax rate and are recognized in the impacted interim period.

Valuation allowances are provided against the future tax benefits that arise from the deferred tax assets in jurisdictions for which no benefit can be recognized. The estimated annual effective tax rate may be significantly impacted by nondeductible expenses and the Company’s projected earnings mix by tax jurisdiction. Adjustments to the estimated annual effective income tax rate are recognized in the period when such estimates are revised.

Inventories are stated at the lower of cost or net realizable value. The cost of ~~Specialty Fluids inventories that were classified as assets held for rent was determined using the average cost method. The cost of all other inventories~~inventory is determined using the FIFO method.

Cabot periodically reviews inventory for both potential obsolescence and potential declines in anticipated selling prices. In this review, the Company makes assumptions about the future demand for and market value of the inventory, and based on these assumptions estimates the amount of any obsolete, unmarketable, slow moving, or overvalued inventory. Cabot writes down the value of these inventories by an amount equal to the difference between the cost of the inventory and its estimated net realizable value.

The Company recognizes the funded status of defined benefit pension and other postretirement benefit plans as an asset or liability. This amount is defined as the difference between the fair value of plan assets and the benefit obligation. Pension and post-retirement benefit costs other than service cost are included in Other income (expense) in the Consolidated Statement of Operations. The Company is required to recognize as a component of Other comprehensive income (loss), net of tax, the actuarial gains/losses and prior service costs/credits that arise but were not previously required to be recognized as components of net periodic benefit cost. Other comprehensive income (loss) is adjusted as these amounts are later recognized in income as components of net periodic benefit cost.

In November 2013, the Company purchased all of its joint venture partner’s common stock in the former NHUMO, S.A. de C.V. (“NHUMO”) joint venture. At the close of the transaction, NHUMO issued redeemable preferred stock to the joint venture partner with a repurchase value of $25 million and a fixed dividend rate of 6% per annum. In November 2018, the preferred stock was repurchased for $25 million and a final dividend payment of approximately $1.4 million was made. The preferred stock was accounted for as a financing obligation and was separately presented in the Consolidated Balance Sheets as a current liability as of September 30, 2018.

Accumulated other comprehensive income (loss) (“AOCI”), which is included as a component of stockholders’ equity, includes unrealized gains or losses on ~~available-for-sale marketable securities and~~ derivative instruments, currency translation adjustments in foreign subsidiaries, translation adjustments on foreign equity securities and minimum pension liability adjustments.

In ~~May 2014, the Financial Accounting Standards Board (“FASB”) issued a new standard,~~ ~~Revenue from Contracts with Customers~~, that amended the existing accounting standards for revenue recognition. The standard requires entities to recognize revenue when they transfer promised goods or services to customers in an amount that reflects the consideration the entity expects to be entitled to in exchange for those goods or services. The Company adopted this standard on October 1, 2018 and applied a modified retrospective approach. The comparative information has not been restated and continues to be reported under the accounting standards in effect during those periods, as discussed in the Company’s 2018 10-K.

The adoption of this standard did not have an impact on how the Company recognizes revenue. As such, an adjustment to opening retained earnings was not required. The Company implemented the updates that were necessary to its revenue recognition policy, internal controls, processes and financial statement disclosures as part of this adoption. The updated disclosures are reflected under the heading “Revenue Recognition” within Note B and the Company’s disaggregated revenue is reflected within Note P.

In addition, as part of an assessment performed in connection with adopting this standard, the Company reviewed its classification of by-product sales, which consist of sales generated from the production of steam or electricity from the Company's energy centers primarily from its carbon black manufacturing sites and sales of hydrochloric acid generated from the production of fumed silica. Historically, the Company presented by-product sales as a reduction of Cost of sales within the Consolidated Statement of Operations. However, upon further evaluation of these sales in connection with the implementation of this standard, the Company determined that it is appropriate to present by-product sales as Net sales and other operating revenues. Effective October 1, 2018, these sales are now included within Net sales and other operating revenues in the Consolidated Statement of Operations. This change did not result in a cumulative adjustment to opening retained earnings as it is a classification change within the Consolidated Statement of Operations. If the Company had continued to classify by-product sales within Cost of sales, there would have been a decrease to Net sales and other operating revenues and Cost of sales of $18 million and $58 million for the three and nine months ended June 30, 2019, respectively.

In August 2016, the FASB issued final amendments to clarify how entities should classify certain cash receipts and cash payments on the statement of cash flows, such as distributions received from equity method investees, proceeds from the settlement of insurance claims, and proceeds from the settlement of corporate-owned life insurance policies. The Company adopted this standard on October 1, 2018. The adoption of this standard did not have a material impact to the Company’s consolidated financial statements.

In March 2017, the FASB issued a new standard that amends the requirements on the presentation of net periodic pension and postretirement benefit costs. The new standard requires the service cost component to be presented with other employee compensation costs. The other components will be reported separately outside of operations. Only the service cost component will be eligible for capitalization. Entities are required to use a retrospective transition method to adopt the requirement for separate income statement presentation of the service cost and other components, and a prospective transition method to adopt the requirement to limit the capitalization of benefit cost to the service component. The Company adopted the standard on October 1, 2018 and used a retrospective transition method to reclassify net periodic benefit cost, other than the service component, from Cost of sales, Selling and administrative expenses and Research and technical expenses to Other income (expense) in the Consolidated Statements of Operations for the prior periods presented. In accordance with the standard, the Company utilized prior period footnote disclosures as a practical expedient to apply these retrospective presentations, which is shown in the table below:

In August 2018, the FASB issued a new standard to align the requirements for capitalizing implementation costs incurred in a cloud computing arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The updated guidance also requires an entity to expense the capitalized implementation costs of a cloud computing arrangement that is a service contract over the term of the arrangement and includes expanded disclosure requirements for such costs. The Company adopted this standard prospectively on January 1, 2019. The adoption of this standard did not have a material impact to the Company’s consolidated financial statements.

In February 2016, the FASB issued a new standard for the accounting for leases. This ~~new~~ standard requires lessees to recognize assets and liabilities for most leases, but recognize expenses on their income statements in a manner that is similar to the ~~current~~historical accounting treatment for leases. The ~~standard is applicable for fiscal years beginning after December 15, 2018 and for interim periods within those years, and early adoption is permitted. The~~ Company ~~is currently evaluating the impact of the adoption of this standard on its consolidated financial statements. The Company expects to adopt~~adopted the standard on October 1, 2019 using the modified retrospective optional transition ~~method,~~method. Accordingly, leases in ~~which case~~the prior ~~periods presented will not~~period continue to be ~~restated.~~reported and disclosed in accordance with the Company’s historical accounting treatment. The Company ~~intends to elect~~elected the package of practical expedients ~~which, among other things,~~that permits the Company to not reassess the identification, classification and initial direct costs of leases commencing before the October 1, 2019 effective date and ~~not include~~to exclude short-term leases onfrom the balance sheet. The Company ~~has established a project plan and implementation team that is analyzing~~did not elect the ~~current portfolio of leases~~hindsight practical expedient to determine the lease term for existing leases or the practical expedient to not separate lease and non-lease components to existing leases, as well as new leases, through transition. The Company allocates the total consideration to the lease components and non-lease components on an observable stand-alone price basis to all asset classes.

Adoption of the new lease standard resulted in the recognition of operating lease right-of-use (“ROU”) assets and operating lease liabilities of approximately $106 million and $111 million, respectively, as of October 1, 2019. Refer to Note H for further

details regarding the balance sheet classification of these items. The difference between the operating lease ROU assets and operating lease liabilities reflects the reclassification of historical deferred rent balances of approximately $5 million. The effects of transition to the new standard resulted in 0 cumulative adjustment to retained earnings in the period of adoption. The standard did not materially impact the Company’s Consolidated Statement of ~~adopting~~Operations or Consolidated Statement of Cash Flows. The new standard did not have a material impact on the Company’s liquidity or debt-covenant compliance as of adoption.

In February 2018, the FASB issued a new standard that allows entities to reclassify from Accumulated other comprehensive income (loss) (“AOCI”) to Retained earnings stranded tax effects resulting from changes made as a result of the Tax Cuts and Jobs Act of 2017 (the “Act”). The Company adopted this ~~new standard.~~standard on October 1, 2019 which resulted in the reclassification of a $2 million net gain from AOCI to Retained earnings. The ~~implementation team is also responsible for evaluating and designing the necessary changes~~reclassification was primarily related to the Company’s ~~business processes, lease policies, systems~~pension plans and ~~internal controls to support recognition and disclosure under the new guidance.~~derivative instruments.

In June 2016, the FASB issued a new standard on measurement of credit losses. The standard introduces ~~a new~~an "expected loss" impairment model that applies to most financial assets measured at amortized cost and certain other instruments, including trade and other receivables and other financial assets. Entities are required to estimate expected credit losses over the life of financial assets and record an allowance against the assets’ amortized cost basis to present them at the amount expected to be collected. The new standard is effective for fiscal years beginning after December 15, 2019 and early adoption is permitted. The Company ~~is evaluating~~will adopt this standard ~~and the timing of its adoption.~~effective October 1, 2020. The Company does not expect the adoption of this standard to materially impact the Company’s consolidated financial statements.

In ~~February 2018,~~March 2020, the FASB issued a new standard on Reference Rate Reform, which provides temporary optional expedients and exceptions to the existing guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate ("LIBOR") and other interbank offered rates to alternative reference rates. The standard was effective upon issuance and may generally be applied through December 31, 2022 to any new or amended contracts, hedging relationships, and other transactions that allows entities to reclassify from AOCI to Retained earnings stranded tax effects resulting from changes made as a result of the Tax Cuts and Jobs Act of 2017 (the “Act”). The amendments in this new standard also require certain disclosures about stranded tax effects. The new standard is effective for all entities for fiscal years beginning after December 15, 2018, including interim periods within those years, and early adoption is permitted. reference LIBOR. The Company is currently evaluating ~~this standard and~~ the timing of ~~its adoption. The Company does not expect~~adoption and the impact of the adoption of this standard ~~to materially impact the Company’s~~on its consolidated financial ~~statements.~~statements.

In November 2017, the Company acquired Tech Blend, a North American producer of black masterbatches, for a purchase price of $65 million, paid in cash. The purchase price was subject to a working capital adjustment, which was immaterial. The operating results of the business are included in the Company’s Performance Chemicals segment. The acquisition extended the Company’s global footprint in black masterbatch and compounds and provides a platform to serve global customers and grow in conductive formulations.

In September 2018, the Company acquired NSCC Carbon (Jiangsu) Co. Ltd, a carbon black manufacturing facility in Pizhou, Jiangsu Province, China for a purchase price of $8 ~~million.~~million, subject to certain conditions. The purchase price ~~is payable upon satisfaction~~conditions were satisfied in September 2019 and the purchase price was paid in the first quarter of ~~certain conditions that are expected to be satisfied within the 2019 calendar year and is recorded within Accounts payable and accrued liabilities on the Consolidated Balance Sheets.~~fiscal 2020. The Company has commenced plans to modify this facility to produce specialty ~~carbons. The~~carbons and therefore the plant is temporarily mothballed. The modifications are expected to be completed, and production is expected to commence, in ~~2021. During~~2022. Transition-related costs associated with this acquisition were $1 million and $2 million for the three and nine months ended June 30, 2020, respectively, and $1 million and $4 million for the three and nine months ended June 30, 2019, respectively.

On April 1, 2020, the Company h~~as incurred $1~~ ~~million~~ ~~and $4 million,~~ ~~respectively, of transition-related costs related to this acquisition.~~

~~In June 2019, the Company acquired a customer list, intellectual property, and trade names from~~purchased Shenzhen Sanshun Nano New Materials Co., Ltd (SUSN), a leading ~~masterbatch~~carbon nanotube producer, ~~in Asia. The total~~for an estimated purchase price of $100 million, consisting of: (i) cash consideration of $84 million, net of $1 million acquired (ii) contingent consideration of $3 million to be paid over the two-year period ending March 31, 2022 upon the satisfaction of certain milestones, and (iii) the assumed debt of $13 million. The debt the Company assumed in the transaction was ~~allocated~~repaid in June 2020. The operating results of SUSN were included in the results of the Company's Performance Chemicals segment beginning in the third quarter of fiscal 2020, and totaled approximately $6 million of revenue in the quarter.

The Company incurred acquisition and integration costs of $2 million through June 30, 2020 associated with the transaction, which are included in Selling and administrative expenses and Cost of Sales in the Consolidated Statements of Operations.

The provisional allocation of the purchase price set forth below was based on estimates of the fair value of assets acquired and liabilities assumed as of April 1, 2020.

As part of the purchase price allocation, the Company determined the separately identifiable intangible assets are comprised of developed technologies of $9 million, which will be amortized over 10 years, customer relationships of $4 million, which will be amortized over 20 years, and trademarks of $2 million, which will be amortized over 10 years. The Company estimated the fair values of the identifiable acquisition-related intangible assets based on projections of cash flows that will arise from those assets. The projected cash flows were discounted to determine the fair value of the assets at the date of acquisition. The determination of the fair value of the intangible assets acquired required the use of judgment with regard to assumptions in the discounted cash flow model used and determination of the useful lives of the developed technologies, customer relationships and trademarks.

The excess of the purchase price over the fair value of the tangible net assets and intangible assets acquired was recorded as goodwill. The goodwill recognized is ~~presented in Intangible assets, net on~~attributable to the ~~Consolidated Balance Sheets. The~~growth and operating synergies that the Company expects to realize from this acquisition. Goodwill generated from the acquisition ~~extends the Company’s global footprint in black and white masterbatch in the Specialty Compounds business.~~will not be deductible for tax purposes.

In June 2019, the Company completed the sale of its Specialty Fluids business, an operating segment of the Company, to Sinomine (Hong Kong) Rare Metals Resource Co. Limited, a wholly owned subsidiary of Sinomine Resource Group Co., Ltd. (“Sinomine”), for total proceeds of $133 million, net of $2 million cash transferred, subject to customary post-closing adjustments that are not expected to be material. Five million dollars of the proceeds are being held in escrow, and are included in Prepaid expenses and other current assets on the Consolidated Balance Sheets, pending the issuance of a Certificate of Compliance by the Canada Revenue Agency related to withholding tax on taxable Canadian property.

million. The Company recognized a $20 million impairment charge during the second quarter of fiscal 2019 and a pre-tax loss on the sale of the Specialty Fluids business of $8$9 million in ~~the third quarter of~~ fiscal ~~2019 and a $20 million impairment charge~~2019. The sale was subject to customary post-closing adjustments, which were finalized during the second quarter of fiscal ~~2019. The~~2020 and resulted in an additional pre-tax loss on sale of the Specialty Fluids business does not meet the criteria to be reported as a discontinued operation as it does not constitute a significant strategic business shift for the Company, and has no major effect on operations.

~~As part of the sale, the Company may receive additional cash royalties of up to $5 million for lithium products, payable over a ten-year period.~~$1 million.

Net periodic defined benefit pension ~~and other postretirement benefit~~ costs include the following:

	Three Months Ended June 30																						Three Months Ended June 30
	2019						2018						2019					2018					2020						2019
	Pension Benefits												Postretirement Benefits										Pension Benefits
	U.S.			Foreign			U.S.			Foreign			U.S.			Foreign		U.S.			Foreign		U.S.			Foreign			U.S.			Foreign
	(In millions)																						(In millions)
Service cost	$	1		$	2		$	1		$	2		$	—		$	—	$	—		$	—	$	—		$	1		$	1		$	2
Interest cost		1			1			1			2			—			—		1			—		1			1			1			1
Expected return on plan assets		(2	)		(2	)		(3	)		(4	)		—			—		—			—		(1	)		(2	)		(2	)		(2	)
Amortization of prior service cost (credit)		—			2			—			—			—			—		(1	)		—
Amortization of actuarial loss		—			1			—			1			(1	)		—		—			—
Settlement and curtailment gain		—			—			—			—			—			—		—			—
Amortization of prior service costs (credit)																								—			—			—			2
Amortization of actual loss																								—			1			—			1
Net periodic benefit (credit) cost	$	—		$	4		$	(1	)	$	1		$	(1	)	$	—	$	—		$	—	$	—		$	1		$	—		$	4

	Nine Months Ended June 30																						Nine Months Ended June 30
	2019						2018						2019					2018					2020						2019
	Pension Benefits												Postretirement Benefits										Pension Benefits
	U.S.			Foreign			U.S.			Foreign			U.S.			Foreign		U.S.			Foreign		U.S.			Foreign			U.S.			Foreign
	(In millions)																						(In millions)
Service cost	$	1		$	5		$	1		$	6		$	—		$	—	$	—		$	—	$	1		$	4		$	1		$	5
Interest cost		4			4			3			6			1			—		1			—		3			3			4			4
Expected return on plan assets		(7	)		(8	)		(8	)		(11	)		—			—		—			—		(3	)		(7	)		(7	)		(8	)
Amortization of prior service cost (credit)		—			2			—			—			(1	)		—		(2	)		—		—			—			—			2
Amortization of actuarial loss		—			2			—			2			(1	)		—		—			—		—			2			—			2
Settlement and curtailment gain		—			(6	)		—			—			—			—		—			—		—			—			—			(6	)
Net periodic benefit (credit) cost	$	(2	)	$	(1	)	$	(4	)	$	3		$	(1	)	$	—	$	(1	)	$	—	$	1		$	2		$	(2	)	$	(1	)

Other postretirement benefit costs were less than $1 million and $1 million for the three and nine months ended June 30, 2020, respectively. Other postretirement benefit gains were less than $1 million for both the three and nine months ended June 30, 2019.

In fiscal 2019, the Company’s Board of Directors approved a resolution to terminate the Company’s U.S. pension plan. The Company commenced the U.S. plan termination process during the third quarter of fiscal 2019 and expects to complete the transfer of the U.S. plan’s assets to participants by the end of calendar year 2020. The pension liability will be settled through a combination of lump-sum payments and purchased annuities. Upon settlement of the benefit liabilities accrued in the plan, the Company ~~adjusted~~will recognize a loss associated with the ~~assumptions~~release of approximately $13 million from AOCI in ~~its U.K. plan~~the Consolidated Balance Sheet to ~~calculate accrued benefits for a portion of the plan’s participants. As a result of this change, a prior service cost of $2 million was recorded in~~ Other income (expense) in the Consolidated Statement of ~~Operations.~~Operations and will also recognize in Other income (expense) any additional gain or loss between the fair value of plan assets and the benefit plan liability on the date of settlement.

In ~~December 2018,~~fiscal 2019, the Company transferred the majority of the defined benefit obligations and pension plan assets in ~~one~~1 of its foreign defined benefit plans to a multi-employer plan. This action moved the administrative, asset custodial, asset investment, actuarial, communication and benefit payment obligations to the multi-employer fund administrator. As a result of the transfer, ~~there was a $30 million reduction in net pension obligations associated with the plan, and~~ a pre-tax gain of $6 million was recorded in the first quarter of fiscal 2019, which is included in Other income (expense) in the Consolidated Statement of Operations. The pre-tax gain consisted of a curtailment credit of less than $1 million for the accelerated recognition of prior service credit and a settlement credit of $5 million for the accelerated recognition of the unrecognized gain upon the transfer of the assets. As of June 30, 2019, approximately $1 million of plan assets remain to be transferred. Such assets are expected to be transferred by the end of fiscal 2019 and such transfer may result in an additional immaterial settlement gain or loss. In addition, as part of the transfer, the Company recorded a $3 million charge in the first quarter of fiscal 2019 ~~for~~reflecting the Company’s agreement to fund the actuarial loss gap between the terminated plan and the multi-employer ~~plan, which will be paid over the next five years.~~plan. This charge is included in Other income (expense) in the Consolidated Statement of ~~Operations and the liability is included in Accounts payable and accrued liabilities and Other liabilities on the Consolidated Balance Sheet.~~Operations.

During the second quarter of fiscal 2018, the Company recorded impairment charges relating to the goodwill and long-lived assets of the Purification Solutions reporting unit, and an associated deferred tax benefit, in the Consolidated Statement of Operations as follows:

In the second quarter of fiscal 2018, the Purification Solutions reporting unit had experienced market share losses, lower customer demand and declining prices in the mercury removal and North America powdered activated carbon applications, which led the Company to reassess its previous estimates for expected growth in volumes, prices and margins in the reporting unit. Due to the revised forecasts at the time, the Company performed a quantitative goodwill impairment test and determined that the estimated fair value of the Purification Solutions reporting unit was lower than the reporting unit's carrying value, resulting in a goodwill impairment charge of $92 million.

Prior to determining the goodwill impairment charge, the Company considered whether the assets of the reporting unit were recoverable. As a result of that assessment, the Company recorded an inventory reserve adjustment of $13 million and impairments to long-lived assets of $162 million. The adjustment to inventory carrying value was determined based on reassessments of volumes, pricing, and margins for the reporting unit at the time and was recorded in Cost of sales in the Consolidated Statements of Operations. The impairment analysis to assess if definite-lived intangible assets and property, plant and equipment were recoverable was based on the estimated undiscounted cash flows of the reporting unit, and these cash flows were not sufficient to recover the carrying value of the long-lived assets over their remaining useful lives. Accordingly, the Company recorded impairment charges of $64 million and $98 million to its definite-lived intangible assets and property, plant and equipment, respectively, in the quarter ended March 31, 2018 based on the lower of the carrying amount or fair value of the long-lived assets.

~~Cabot will continue to monitor for events or changes in business circumstances that may indicate that the remaining carrying value of the asset group may not be recoverable.~~

Additionally, the Company recorded a tax benefit related to the impairment charges of $30 million in the second quarter of fiscal 2018, which was subsequently reduced by $1 million after the impairment charges by tax jurisdictions were finalized.

The carrying amount of goodwill attributable to each reportable segment with goodwill balances and the changes in those balances during the nine month period ended June 30, ~~2019~~2020 are as follows:

⁽¹⁾Consists of goodwill acquired in the acquisition of SUSN as described in Note C.

The following table provides information regarding the Company’s intangible assets:

	June 30, 2019							September 30, 2018							June 30, 2020							September 30, 2019
	Gross Carrying Value		Accumulated Amortization			Net Intangible Assets		Gross Carrying Value		Accumulated Amortization			Net Intangible Assets		Gross Carrying Value		Accumulated Amortization			Net Intangible Assets		Gross Carrying Value		Accumulated Amortization			Net Intangible Assets
	(In millions)														(In millions)
Intangible assets with finite lives
Developed technologies	$	51	$	(4	)	$	47	$	52	$	(2	)	$	50	$	58	$	(7	)	$	51	$	50	$	(5	)	$	45
Trademarks		8		—			8		8		—			8		11		(1	)		10		8		—			8
Customer relationships		58		(13	)		45		51		(11	)		40		54		(13	)		41		57		(14	)		43
Total intangible assets(1)	$	117	$	(17	)	$	100	$	111	$	(13	)	$	98	$	123	$	(21	)	$	102	$	115	$	(19	)	$	96

⁽¹⁾Total intangible assets as of June 30, 2020 includes $15 million of intangible assets from the acquisition of SUSN as described in Note C and an unfavorable impact of foreign currency translation of $4 million.

Intangible assets are amortized over their estimated useful lives, which range between ~~twelve~~ten and twenty-five years, with a weighted average amortization period of approximately ~~nineteen~~eighteen years. Amortization expense for ~~both~~the three ~~month periods~~months ended June 30, 2020 and 2019 was $2 million and ~~2018 was~~ $1 million, respectively, and for the nine months ended June 30, 2020 and 2019 was $5 million and $4 million, respectively. Amortization expense is included in Cost of sales, Selling and administrative expenses, and ~~research~~Research and technical expenses in the Consolidated Statements of Operations.  Amortization expense for the nine month periods ended June 30, 2019 and 2018 was $4 million and $6 million, respectively, and is included in Cost of sales, Selling and administrative expenses, and research and technical expenses in the Consolidated Statements of Operations. Total amortization expense is estimated to be approximately $6$7 million each year for the next five fiscal years.

Comprehensive income combines net income (loss) and other comprehensive income items, which are reported as components of stockholders’ equity in the accompanying Consolidated Balance Sheets.

	Currency Translation Adjustment			Unrealized Gains on Investments		Pension and Other Postretirement Benefit Liability Adjustments			Total			Currency Translation Adjustment			Unrealized Gains on Investments			Pension and Other Postretirement Benefit Liability Adjustments			Total
	(In millions)											(In millions)
Balance at September 30, 2018, attributable to Cabot Corporation	$	(266	)	$	1	$	(52	)	$	(317	)
Balance at September 30, 2019, attributable to Cabot Corporation												$	(338	)	$	1		$	(54	)	$	(391	)
Other comprehensive income (loss) before reclassifications													43			—			—			43
Amounts reclassified from AOCI													(1	)		—			1			—
Adoption of accounting standards													(3	)		(1	)		1			(3	)
Less: Other comprehensive income (loss) attributable to noncontrolling interests													3			—			—			3
Balance at December 31, 2019, attributable to Cabot Corporation													(302	)		—			(52	)		(354	)
Other comprehensive income (loss) before reclassifications													(78	)		—			—			(78	)
Less: Other comprehensive income (loss) attributable to noncontrolling interests													(3	)		—			—			(3	)
Balance at March 31, 2020, attributable to Cabot Corporation													(377	)		—			(52	)		(429	)
Other comprehensive income (loss) before reclassifications		(24	)		—		30			6			31			—			(1	)		30
Amounts reclassified from AOCI		(1	)		—		(8	)		(9	)		(1	)		—			2			1
Less: Other comprehensive income (loss) attributable to noncontrolling interests		—			—		—			—			2			—			—			2
Balance at December 31, 2018, attributable to Cabot Corporation	$	(291	)	$	1	$	(30	)	$	(320	)
Other comprehensive income (loss) before reclassifications		8			—		1			9
Amounts reclassified from AOCI		(1	)		—		(1	)		(2	)
Less: Other comprehensive income (loss) attributable to noncontrolling interests		2			—		—			2
Balance at March 31, 2019, attributable to Cabot Corporation		(286	)		1		(30	)		(315	)
Other comprehensive income (loss) before reclassifications		1			—		(1	)		—
Amounts reclassified from AOCI		—			—		2			2
Less: Other comprehensive income (loss) attributable to noncontrolling interests		(2	)		—		—			(2	)
Balance at June 30, 2019, attributable to Cabot Corporation	$	(283	)	$	1	$	(29	)	$	(311	)
Balance at June 30, 2020, attributable to Cabot Corporation												$	(349	)	$	—		$	(51	)	$	(400	)

The amounts reclassified out of AOCI and into the Consolidated Statements of Operations in the three and nine months ended June 30, ~~2019~~2020 and ~~2018~~2019 were as follows:

	Affected Line Item in the Consolidated	Three Months Ended June 30						Nine Months Ended June 30						Affected Line Item in the Consolidated	Three Months Ended June 30						Nine Months Ended June 30
	Statements of Operations	2019			2018			2019			2018			Statements of Operations	2020			2019			2020			2019
		(In millions)													(In millions)
Derivatives: net investment hedges
(Gains) losses reclassified to interest expense	Interest expense	$	(1	)	$	(2	)	$	(4	)	$	(4	)	Interest expense	$	(2	)	$	(1	)	$	(4	)	$	(4	)
(Gains) losses excluded from effectiveness testing and amortized to interest expense	Interest expense	$	—		$	—		$	1		$	—		Interest expense		—			—			1			1
Pension and other postretirement benefit liability adjustment
Amortization of actuarial losses	Net Periodic Benefit Cost - see Note E for details		—			1			1			2
Amortization of prior service cost (credit)	Net Periodic Benefit Cost - see Note E for details		2			(1	)		1			(2	)
Pension and other postretirement
Amortization of actuarial losses and prior service cost (credit)														Net Periodic Benefit Cost - see Note D for details		2			2			3			2
Settlement and curtailment gain	Net Periodic Benefit Cost - see Note E for details		—			—			(6	)		—		Net Periodic Benefit Cost - see Note D for details		—			—			—			(6	)
Total before tax			1			(2	)		(7	)		(4	)			—			1			—			(7	)
Tax impact	Provision (benefit) for income taxes		1			1			(2	)		1		Provision (benefit) for income taxes		1			1			1			(2	)
Total after tax		$	2		$	(1	)	$	(9	)	$	(3	)		$	1		$	2		$	1		$	(9	)

Cabot has entered into long-term purchase agreements primarily for the purchase of raw materials. Under certain of these agreements, the quantity of material being purchased is fixed, but the price paid changes as market prices change. For these purchase commitments, the amounts included in the table below are based on market prices at June 30, 2019, which may differ from actual market prices at the time of purchase.

Cabot has provided certain indemnities pursuant to which it may be required to make payments to an indemnified party in connection with certain transactions and agreements. In connection with certain acquisitions and divestitures, Cabot has provided routine indemnities with respect to such matters as environmental, tax, insurance, product and employee liabilities. In connection with various other agreements, including service and supply agreements with customers, Cabot has provided indemnities for certain contingencies and routine warranties. Cabot is unable to estimate the maximum potential liability for these types of indemnities as a maximum obligation is not explicitly stated in most cases and the amounts, if any, are dependent upon the outcome of future contingent events, the nature and likelihood of which cannot be reasonably estimated. The duration of the indemnities vary, and in many cases are indefinite. Cabot has not recorded any liability for these indemnities in the consolidated financial statements, except as otherwise disclosed.

~~Cabot is a defendant, or potentially responsible party, in various lawsuits and environmental proceedings wherein substantial amounts are claimed or at issue.~~

As of June 30, 2019 and September 30, 2018, Cabot had $14 million and $15 million, respectively, reserved for environmental matters. These environmental matters mainly relate to former operations. The Company’s reserves for environmental matters represent Cabot’s best estimates of the probable costs to be incurred at those sites where costs are reasonably estimable based on the Company’s analysis of the extent of clean up required, alternative clean-up methods available, abilities of other responsible parties to contribute and its interpretation of laws and regulations applicable to each site.

Cash payments related to these environmental matters were $1 million and $2 million in the first nine months of fiscal 2019 and fiscal 2018, respectively. Cabot reviews the adequacy of the reserves as circumstances change at individual sites and adjusts the reserves as appropriate. Almost all of Cabot’s environmental issues relate to sites that are mature and have been investigated and studied and, in many cases, are subject to agreed upon remediation plans. However, depending on the results of future testing, changes in risk assessment practices, remediation techniques and regulatory requirements, newly discovered conditions, and other factors, it is reasonably possible that the Company could incur additional costs in excess of environmental reserves currently recorded. Management estimates, based on the latest available information, that any such future environmental remediation costs that are reasonably possible to be in excess of amounts already recorded would be immaterial to the Company’s consolidated financial statements.

Cabot has exposure in connection with a safety respiratory products business that a subsidiary acquired from American Optical Corporation (“AO”) in an April 1990 asset purchase transaction. The subsidiary manufactured respirators under the AO brand and disposed of that business in July 1995. In connection with its acquisition of the business, the subsidiary agreed, in certain circumstances, to assume a portion of AO’s liabilities, including costs of legal fees together with amounts paid in settlements and judgments, allocable to AO respiratory products used prior to the 1990 purchase by the Cabot subsidiary. In exchange for the subsidiary’s assumption of certain of AO’s respirator liabilities, AO agreed to provide to the subsidiary the benefits of: (i) AO’s insurance coverage for the period prior to the 1990 acquisition and (ii) a former owner’s indemnity of AO holding it harmless from any liability allocable to AO respiratory products used prior to May 1982. As more fully described in the ~~2018~~2019 10-K, the respirator liabilities generally involve claims for personal injury, including asbestosis, silicosis and coal worker’s pneumoconiosis, allegedly resulting from the use of respirators that are alleged to have been negligently designed and/or labeled. Neither Cabot, nor its past or present subsidiaries, at any time manufactured asbestos or asbestos-containing products. At no time did this respiratory product line represent a significant portion of the respirator market. In addition to Cabot’s subsidiary, other parties are responsible for significant portions of the costs of these respirator liabilities (as defined in the 2019 10-K, the “Payor Group”).

As On February 28, 2020, Cabot, with certain members of the Payor Group, entered into a settlement agreement resolving a large group of claims, including claims alleging serious injury, brought by coal workers in Kentucky and West Virginia represented by common legal counsel. The Company’s share of this liability is $65.2 million, and during the second quarter of fiscal 2020, Cabot recorded a charge of $50 million for this settlement, which was included in Selling and administrative expenses in the Consolidated Statements of Operations. The Company paid $32.6 million of the settlement during the third quarter of fiscal 2020 and the remaining $32.6 million, which is included in Accounts payable and accrued liabilities on the Consolidated Balance Sheets as of June 30, ~~2019, and September 30, 2018, there were approximately 36,000 and 35,000 claimants, respectively,~~2020, will be paid in ~~pending cases asserting claims against AO in connection with respiratory products.~~the first quarter of fiscal 2021.

In addition to the February 2020 settlement, Cabot has a reserve to cover its expected share of ~~liability~~liabilities for existing and future respirator liability ~~claims.~~

claims, which is included in Other liabilities and Accounts payable and accrued liabilities on the Consolidated Balance Sheets. The Company expects these liabilities to be incurred over a number of years. The reserve was $21 million and $35 million as of June 30, 2020 and September 30, 2019, respectively. The Company’s current estimate of the cost of its share of existing and future respirator liability claims is based on facts and circumstances existing at this ~~time.~~ time, including the nature of the remaining claims. Because reserves are limited to amounts that are probable and estimable as of a relevant measurement date, and there is inherent difficulty in projecting the impact of potential developments on Cabot’s share of liability for these existing and future claims, the actual amount of liabilities related to these claims could be different from Cabot’s reserve.

Developments that could affect the Company’s estimate include, but are not limited to, (i) significant changes in the number of future claims, (ii) changes in the rate of dismissals without payment of pending claims, (iii) significant changes in the average cost of resolving claims, including potential settlements of groups of claims, (iv) significant changes in the legal costs of defending these claims, (v) changes in the nature of claims received, (vi) trial and appellate outcomes, (vii) changes in the law and procedure applicable to these claims, (viii) the financial viability of the parties that contribute to the settlement of respirator claims, (ix) ~~a change in~~exhaustion of the ~~availability of~~ insurance coverage maintained by certain of the parties that contribute to the settlement of respirator claims, or a change in the availability of the indemnity provided by a former owner of the business, (x) changes in the allocation of costs among the various parties paying legal and settlement costs, and (xi) a determination that the assumptions that were used to estimate Cabot’s share of liability are no longer reasonable. The Company cannot determine the impact of these potential developments on its current estimate of its share of liability for existing and future claims. Accordingly, the actual amount of these liabilities for existing and future claims could be larger than the reserved amount.

At June 30, 2019 and September 30, 2018, the reserve to cover the Company’s expected share of liability for existing and future respirator liability claims was $21 million and $25 million, respectively. The Company made payments related to its respirator liability of $4 million and $1 million in the first nine months of fiscal 2019 and fiscal 2018, respectively.

The Company has various other lawsuits, claims and contingent liabilities arising in the ordinary course of its business and with respect to its divested businesses. The Company does not believe that any of these matters will have a material adverse effect on its financial position; however, litigation is inherently unpredictable. Cabot could incur judgments, enter into settlements or revise its expectations regarding the outcome of certain matters, and such developments could have a material impact on its results of operations in the period in which the amounts are accrued or its cash flows in the period in which the amounts are paid.

The Company determines if an arrangement is a lease at inception. The Company considers a contract to be or to contain a lease if the contract conveys the right to control the use of identified property, plant, or equipment (an identified asset) for a period of time in exchange for consideration.

A lease liability is recorded at commencement for the net present value of future lease payments over the lease term. The discount rate used is generally the Company’s estimated incremental borrowing rate based on credit-adjusted and term-specific discount rates, using a third-party yield curve. An ROU asset is recorded and recognized at commencement at the lease liability amount, including initial direct costs incurred, and is reduced for lease incentives received. The Company’s lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option.

In the normal course of its business, the Company enters into various leases as the lessee, primarily related to certain transportation vehicles, warehouse facilities, office space, and machinery and equipment. These leases have remaining lease terms between one and nineteen years, some of which may include options to extend the leases for up to fifteen years or options to terminate the leases. The Company’s land leases have remaining lease terms up to seventy years.

Some lease arrangements require variable payments that are dependent on usage, output, or index-based adjustments. The Company does not have material variable lease payments.

The Company has elected not to recognize short-term leases on the balance sheet for all underlying asset classes. Short-term leases are leases that, at the commencement date, have a lease term of twelve months or less and do not include a purchase option that the Company is reasonably certain to exercise. Short-term leases are expensed on a straight-line basis over the lease term.

For the three and nine months ended June 30, 2020, short-term lease costs were $1 million and $5 million, respectively. For both the three and nine months ended June 30, 2020, variable lease costs were less than $1 million.

Supplemental cash flow information related to the Company’s leases was as follows:

Supplemental balance sheet information related to the Company’s leases was as follows:

The following table presents the weighted-average remaining lease term and discount rates for the Company’s leases as of June 30, 2020:

Future minimum lease payments under non-cancelable operating and finance leases as of June 30, 2020 were as follows:

The Company’s future minimum lease payments under noncancelable leases as of September 30, 2019 were as follows:

	Three Months Ended June 30						Nine Months Ended June 30						Three Months Ended June 30						Nine Months Ended June 30
	2019			2018			2019			2018			2020			2019			2020			2019
	(Dollars in millions)												(Dollars in millions)
(Provision) benefit for income taxes	$	(30	)	$	4		$	(43	)	$	(194	)	$	5		$	(30	)	$	(9	)	$	(43	)
Effective tax rate		43	%		(3	)%		23	%		1202	%		51	%		43	%		17	%		23	%

For the three and nine months ended June 30, 2020, the (Provision) benefit for income taxes included a net discrete tax benefit of $2 million and $14 million, respectively. The $14 million was comprised of $8 million related to changes in uncertain tax positions and $6 million related to the impacts of Switzerland tax reform legislation. For the three and nine months ended June 30, 2019,, the ~~tax (provision)~~(Provision) benefit for income taxes included a net discrete tax expense of $13 million and a net discrete tax benefit of $11 million, respectively. Of these amounts, a net tax expense of $17 million and ~~zero,~~a nil amount, respectively, are related to U.S. tax reform ~~legislation described below.~~ ~~For the three and nine months ended June 30, 2018,~~ the tax (provision) benefit included a net discrete tax benefit of $23 million and a net discrete tax expense of $139 million, respectively. Of these amounts, a net tax benefit of $4 million and a net tax expense of $185 million, respectively, are related to U.S. tax reform legislation described below.

On December 22, 2017, the U.S. enacted significant changes to federal income tax law affecting the Company, including a permanent reduction of the U.S. corporate income tax rate from 35% to 21%, effective January 1, 2018, as well as a 100% dividend received deduction for foreign dividends. Although the passage of the Act reduced the U.S. tax rate and effectively created a participation exemption regime for foreign earnings, in transitioning to this participation exemption regime, Cabot was also subject, during fiscal 2018, to a one-time tax on the deemed repatriation of certain foreign earnings (the “transition tax”).

As provided in Staff Accounting Bulletin 118 (“SAB 118”), the Company made certain final adjustments during the first quarter of fiscal 2019, including, in particular, the recording of a $17 million tax benefit related to the U.S. taxation of deemed foreign dividends in the transition fiscal year. During the quarter ended June 30, 2019, the U.S. Department of the Treasury issued final regulations denying fiscal year taxpayers the ability to claim a deduction for the gross-up portion of foreign dividends attributable to the transition tax. As a result, the Company reversed the original benefit resulting in an additional tax expense of $17 million in the third quarter of fiscal 2019 related to the U.S. taxation of deemed foreign dividends in the transition fiscal year.legislation.

Cabot and certain subsidiaries are under audit in a number of jurisdictions. In addition, certain statutes of limitations are scheduled to expire in the near future. It is reasonably possible that a further change in the unrecognized tax benefits may also occur within the next twelve months related to the settlement of one or more of these audits or the lapse of applicable statutes of limitations. However, an estimated range of the impact on the unrecognized tax benefits cannot be quantified at this time.

Cabot files U.S. federal and state and non-U.S. income tax returns in jurisdictions with varying statutes of limitations. The ~~2014~~2016 through ~~2017~~2019 tax years generally remain subject to examination by the IRS and various tax years from 2005 through ~~2017~~2019 remain subject to examination by the respective state tax authorities. In significant non-U.S. jurisdictions, various tax years from ~~2002~~2003 through ~~2017~~2019 remain subject to examination by their respective tax authorities. As of June 30, ~~2019,~~2020, Cabot’s significant non-U.S. jurisdictions include Canada, China, France, Germany, Italy, Japan, Switzerland and the Netherlands.

During the three and nine months ended June 30, 2020, Cabot released uncertain tax positions of $3 million and $11 million, respectively, due to audit settlements and the expiration of statutes of limitations in various jurisdictions. During the three and nine months ended June 30, 2019, Cabot released uncertain tax positions of $1 million and $9 million, respectively, due to audit settlements and the expiration of statutes of limitations in various jurisdictions. During the three months ended June 30, 2018, Cabot did not release any uncertain tax positions. During the nine months ended June 30, 2018, Cabot released uncertain tax positions of $2 million due to the expiration of statutes of limitations in various jurisdictions.

The following tables summarize the components of the basic and diluted earnings (loss) per common share (“EPS”) computations:

	Three Months Ended June 30				Nine Months Ended June 30					Three Months Ended June 30					Nine Months Ended June 30
	2019		2018		2019		2018			2020			2019		2020		2019
	(In millions, except per share amounts)									(In millions, except per share amounts)
Basic EPS:
Net income (loss) attributable to Cabot Corporation	$	32	$	88	$	124	$	(207	)	$	(6	)	$	32	$	34	$	124
Less: Undistributed earnings allocated to participating securities⁽¹⁾		—		—		—		—
Less: Dividends and dividend equivalents to participating securities											—			—		—		—
Earnings (loss) allocated to common shareholders (numerator)	$	32	$	88	$	124	$	(207	)	$	(6	)	$	32	$	34	$	124

Weighted average common shares and participating securities outstanding		59.0		62.5		59.9		62.5			57.2			59.0		57.4		59.9
Less: Participating securities⁽¹⁾		0.8		0.7		0.8		0.7			0.7			0.8		0.7		0.8
Adjusted weighted average common shares (denominator)		58.2		61.8		59.1		61.8			56.5			58.2		56.7		59.1

Earnings (loss) per common share - basic:	$	0.55	$	1.41	$	2.08	$	(3.36	)	$	(0.12	)	$	0.55	$	0.59	$	2.08

Diluted EPS:
Earnings (loss) allocated to common shareholders	$	32	$	88	$	124	$	(207	)	$	(6	)	$	32	$	34	$	124
Plus: Earnings (loss) allocated to participating securities		—		1		1		1
Plus: Earnings allocated to participating securities											—			—		—		1
Less: Adjusted earnings allocated to participating securities⁽²⁾		—		1		1		1			—			—		—		1
Earnings (loss) allocated to common shareholders (numerator)	$	32	$	88	$	124	$	(207	)	$	(6	)	$	32	$	34	$	124

Adjusted weighted average common shares outstanding		58.2		61.8		59.1		61.8			56.5			58.2		56.7		59.1
Effect of dilutive securities:
Common shares issuable⁽³⁾		0.2		0.5		0.1		—			—			0.2		—		0.1
Adjusted weighted average common shares (denominator)		58.4		62.3		59.2		61.8			56.5			58.4		56.7		59.2

Earnings (loss) per common share - diluted:	$	0.55	$	1.40	$	2.08	$	(3.36	)	$	(0.12	)	$	0.55	$	0.59	$	2.08

Undistributed earnings are the earnings which remain after dividends declared during the period are assumed to be distributed to the common and participating shareholders. Undistributed earnings are allocated to common and participating shareholders on the same basis as dividend distributions. The calculation of undistributed earnings is as follows:

	Three Months Ended June 30				Nine Months Ended June 30					Three Months Ended June 30					Nine Months Ended June 30
	2019		2018		2019		2018			2020			2019		2020			2019
	(In millions)									(In millions)
Calculation of undistributed earnings (loss):
Net income (loss) attributable to Cabot Corporation	$	32	$	88	$	124	$	(207	)	$	(6	)	$	32	$	34		$	124
Less: Dividends declared on common stock		20		21		60		60			20			20		60			60
Less: Dividends declared on participating securities											—			—		—			—
Undistributed earnings (loss)	$	12	$	67	$	64	$	(267	)	$	(26	)	$	12	$	(26	)	$	64

Allocation of undistributed earnings (loss):
Undistributed earnings (loss) allocated to common shareholders	$	12	$	67	$	64	$	(267	)	$	(26	)	$	12	$	(26	)	$	64
Undistributed earnings allocated to participating shareholders											—			—		—			—
Undistributed earnings (loss)	$	12	$	67	$	64	$	(267	)	$	(26	)	$	12	$	(26	)	$	64

Cabot’s restructuring activities were recorded in the Consolidated Statements of Operations in the three and nine months ended June 30, ~~2019~~2020 and ~~2018~~2019 as follows:

	Three Months Ended June 30				Nine Months Ended June 30					Three Months Ended June 30				Nine Months Ended June 30
	2019		2018		2019		2018			2020		2019		2020		2019
	(In millions)									(In millions)
Cost of sales	$	2	$	1	$	7	$	(8	)	$	—	$	2	$	5	$	7
Selling and administrative expenses		2		—		8		1			3		2		11		8
Total	$	4	$	1	$	15	$	(7	)	$	3	$	4	$	16	$	15

Details of all restructuring activities and the related reserves during the three and nine months ended June 30, ~~2019~~2020 were as follows:

	Severance and Employee Benefits			Environmental Remediation		Asset Impairment and Accelerated Depreciation			Other			Total			Severance and Employee Benefits			Environmental Remediation		Accelerated Depreciation and Idle Asset Depreciation			Other			Total
	(In millions)														(In millions)
Reserve at September 30, 2018	$	1		$	4	$	—		$	—		$	5
Reserve at September 30, 2019															$	3		$	4	$	—		$	—		$	7
Charges (gain)																7			—		—			1			8
Cash paid																(2	)		—		—			(1	)		(3	)
Reserve at December 31, 2019																8			4		—			—			12
Charges (gain)		7			—		1			1			9			3			—		1			1			5
Costs charged against assets / (liabilities)		—			1		(1	)		—			—			—			—		(1	)		—			(1	)
Cash paid		(1	)		—		—			(1	)		(2	)		(5	)		—		—			(1	)		(6	)
Reserve at December 31, 2018		7			5		—			—			12
Reserve at March 31, 2020																6			4		—			—			10
Charges (gain)		1			—		—			1			2			1			—		—			2			3
Costs charged against assets / (liabilities)		—			—		—			—			—
Cash paid		(1	)		—		—			(1	)		(2	)		(2	)		—		—			(2	)		(4	)
Reserve at March 31, 2019		7			5		—			—			12
Charges (gain)		2			—		1			1			4
Costs charged against assets / (liabilities)		—			—		(1	)					(1	)
Cash paid		(2	)		—		—			(1	)		(3	)
Reserve at June 30, 2019	$	7		$	5	$	—		$	—		$	12
Reserve at June 30, 2020															$	5		$	4	$	—		$	—		$	9

Cabot’s severance and employee benefit reserves and other closure related reserves are reflected in Accounts payable and accrued liabilities on the Company’s Consolidated Balance Sheets. Cabot’s environmental remediation reserves related to restructuring activities are reflected in Other liabilities on the Company’s Consolidated Balance Sheets.

During the first nine months of fiscal 2020, the Company initiated several actions that it believes will enable the Company to perform certain activities more cost-effectively. These actions primarily consist of the reorganization of Cabot’s leadership structure, the creation of a Global Business Services function and other operational efficiency initiatives. As part of the creation of the Global Business Services function, certain business service activities performed at Cabot’s North American business service center are being consolidated into the Company’s European business service center. During the three and nine months ended June 30, 2020, the Company recorded charges of $3 million and $15 million, respectively, for these actions, primarily related to severance costs. The Company expects to record additional restructuring charges, primarily related to site demolition and clearing costs associated with the Company’s other operational efficiency initiatives, of approximately $1 million in fiscal 2020 and $5 million thereafter. Cabot paid approximately $3 million and $10 million related to these activities in the three and nine months ended June 30, 2020, respectively, and expects to pay approximately $3 million in the remainder of fiscal 2020 and $7 million thereafter. As of June 30, 2020, Cabot had $5 million of accrued severance charges in the Consolidated Balance Sheets related to these actions.

In December 2018, the Company ~~began implementation of~~initiated a transformation plan to improve the long-term performance of the Purification Solutions segment. The purpose of the plan is to focus the business’s product portfolio, optimize its manufacturing assets, and streamline its organizational structure to support the new focus. The Company expects to record total charges of $10 million related to this plan, of which approximately $9 million was recorded in fiscal 2019, comprised of severance, employee benefits and professional service fees. The Company recorded nominal charges in the three months ended June 30, 2020 and $1 million of charges in the nine months ended June 30, 2020. The Company recorded charges of less than $1 million ~~of severance costs related to this plan in the three months ended June 30, 2019~~ and ~~recorded charges of approximately~~ $9 million related to this plan in the nine months ended June 30, 2019, comprised of approximately $8 million of severance costs and $1 million of professional fees. The Company expects to record cash charges of approximately $1 million in the remainder of fiscal 2019 and thereafter for additional restructuring charges related to this plan. Cabot paid approximately $2 million and $4 million related to these activities in the three and nine months ended June 30, 2019, ~~respectively,~~respectively. The Company expects to record nominal charges in the future related to this plan. Cabot paid approximately $9 million related to these activities through June 30, 2020, $8 million of which was paid in fiscal 2019, and expects to pay ~~approximately $6~~$1 million in the remainder of fiscal ~~2019 and thereafter.~~2020. As of June 30, ~~2019,~~2020, Cabot had $5less than $1 million of accrued severance and other employee benefit charges in the Consolidated Balance Sheets related to these actions.

As part the Company’s 2016 restructuring plan, the Company ceased operations at its carbon black manufacturing facility in Merak, Indonesia in January 2016 and completed the sale of the land on which the facility was located in the second quarter of fiscal 2018 for cash consideration totaling approximately $13 million, resulting in a net pre-tax gain of approximately $11 million recorded to Cost of sales in the Company’s Consolidated Statements of Operations.

The FASB authoritative guidance on fair value measurements defines fair value, provides a framework for measuring fair value, and requires certain disclosures about fair value measurements. The required disclosures focus on the inputs used to measure fair value. The guidance establishes the following hierarchy for categorizing these inputs:

There were no0 transfers of financial assets or liabilities measured at fair value between Level 1 and Level 2 and there were no Level 3 investments during the first nine months of either fiscal ~~2019~~2020 or ~~2018.~~2019.

At June 30, ~~2019~~2020 and September 30, ~~2018,~~2019, Cabot had derivatives relating to foreign currency risks, including a net investment hedge and forward foreign currency contracts, carried at fair value. At June 30, ~~2019 and September 30, 2018,~~2020, the fair value of these derivatives was a net ~~liability~~asset of $8$10 million and ~~$18~~was included in Prepaid expenses and other current assets, Accounts payable and accrued liabilities, and Other assets on the Consolidated Balance Sheets. At September 30, 2019, the fair value of these derivatives was a net asset of $1 million ~~respectively,~~ and was included in Prepaid expenses and other current assets and Other ~~liabilities~~assets on the Consolidated Balance Sheets. These derivatives are classified as Level 2 instruments within the fair value hierarchy as the fair value determination was based on observable inputs.

At ~~both~~ June 30, ~~2019~~2020 and September 30, ~~2018,~~2019, the fair value of guaranteed investment contracts, included in Other assets on the Consolidated Balance Sheets, was $11 ~~million.~~million and $10 million, respectively. Guaranteed investment contracts were classified as Level 2 instruments within the fair value hierarchy as the fair value determination was based on other observable inputs.

At June 30, ~~2019~~2020 and September 30, ~~2018,~~2019, the fair values of cash and cash equivalents, accounts and notes receivable, accounts payable and accrued liabilities, and short-term borrowings and variable rate debt approximated their carrying values due to the short-term nature of these instruments. The carrying value and fair value of the long-term fixed rate debt were ~~$1,018 million~~$1.15 billion and ~~$1,077 million,~~$1.27 billion, respectively, as of June 30, ~~2019,~~2020, and ~~$747 million~~$1.03 billion and ~~$742 million,~~$1.10 billion, respectively, as of September 30, ~~2018.~~2019. The fair values of Cabot’s fixed rate long-term debt are estimated based on comparable quoted market prices at the respective period ends. The carrying amounts of Cabot’s floating rate long-term debt and ~~capital~~finance and operating lease obligations approximate their fair values. All such measurements are based on observable inputs and are classified as Level 2 within the fair value hierarchy. The valuation technique used is the discounted cash flow model.

In May 2019, several subsidiaries entered into a revolving credit agreement with a loan commitment not to exceed 300 million Euros. The amount available for borrowing under this revolving credit agreement was $294 million as of June 30, 2019. The revolving credit agreement, which matures on May 22, 2024 or earlier upon maturity of the Company’s $1 billion unsecured revolving credit agreement, may be used for repatriation of earnings of Cabot’s foreign subsidiaries to the U.S., the repayment of indebtedness of the Company’s foreign subsidiaries owing to the Company or any of its subsidiaries, and for working capital and general corporate purposes. The obligations of the subsidiaries under the revolving credit agreement are guaranteed by the Company. The Company paid debt issuance costs of $1 million upon entering the agreement, which are being amortized over the life of the revolver.

In June 2019, Cabot issued $300 million in registered, unsecured, notes with a coupon of 4% that mature on July 1, 2029. Interest is payable under the notes semi-annually on January 1 and July 1 commencing in 2020. The net proceeds of this offering were $296 million after deducting discounts and issuance costs of $1 million and $3 million, respectively, which were paid at issuance and are being amortized over the life of the notes.

Cabot’s international operations are subject to certain risks, including currency exchange rate fluctuations and government actions. Cabot endeavors to match the currency in which debt is issued to the currency of the Company’s major, stable cash receipts. In some situations, Cabot has issued debt denominated in U.S. dollars and then entered into cross-currency swaps that exchange the dollar principal and interest payments into Euro-denominated principal and interest payments.

Additionally, the Company has foreign currency exposure arising from its net investments in foreign operations. Cabot may enter into cross-currency swaps to mitigate the impact of currency rate changes on the Company’s net investments.

The Company also has foreign currency exposure arising from the denomination of monetary assets and liabilities in foreign currencies other than the functional currency of a given subsidiary as well as the risk that currency fluctuations could affect the dollar value of future cash flows generated in foreign currencies. Accordingly, Cabot uses short-term forward contracts to minimize the exposure to foreign currency risk. In certain situations where the Company has forecasted purchases under a long-term commitment or forecasted sales denominated in a foreign currency, Cabot may enter into appropriate financial instruments in accordance with the Company’s risk management policy to hedge future cash flow exposures.

The following table provides details of the derivatives held as of June 30, ~~2019~~2020 and September 30, ~~2018~~2019 to manage foreign currency risk.

The Company determines the fair value of financial instruments using quoted market prices whenever available. When quoted market prices are not available for various types of financial instruments (such as forwards, options and swaps), the Company uses standard models with market-based inputs, which take into account the present value of estimated future cash flows and the ability of Cabot or the financial counterparty to perform. For interest rate and cross-currency swaps, the significant inputs to these models are interest rate curves for discounting future cash flows and are adjusted for credit risk. For forward foreign currency contracts, the significant inputs are interest rate curves for discounting future cash flows, and exchange rate curves of the foreign currency for translating future cash flows.

For derivative instruments that are designated and qualify as fair value hedges, the gain or loss on the derivative as well as the offsetting gain or loss on the hedged item attributable to the hedged risk are recognized in current period earnings.

For derivative instruments that are designated and qualify as cash flow hedges, the effective portion of the gain or loss on the derivative is recorded in AOCI and reclassified to earnings in the same period or periods during which the hedged transaction affects earnings. Gains and losses on the derivative representing either hedge ineffectiveness or hedge components excluded from the assessment of effectiveness are recognized in current period earnings.

For net investment hedges, changes in the fair value of the effective portion of the derivatives’ gains or losses are reported as foreign currency translation gains or losses in AOCI while changes in the ineffective portion are reported in earnings. Effectiveness is assessed using the method based on changes in spot exchange rates. The gains or losses on derivative instruments reported in AOCI are reclassified to earnings in the period in which earnings are affected by the underlying item, such as a disposal or substantial liquidations of the entities being hedged.

The Company has cross-currency swaps with a notional amount of $250 million, which are designated as hedges of its net investments in certain Euro-denominated subsidiaries. Cash settlements occur semi-annually on March 15^th and September 15^th for fixed rate interest payments and a cash exchange of the notional currency amount will occur at the end of the term in 2026. As of June 30, ~~2019,~~2020, the fair value of these swaps was a net ~~liability~~asset of $8$10 million and was included in Prepaid expenses and other current assets and Other ~~liabilities~~assets and the cumulative ~~loss~~gain of $5$13 million was included in AOCI on the Consolidated Balance Sheets. As of September 30, ~~2018,~~2019, the fair value of these swaps was a net ~~liability~~asset of ~~$18~~$1 million and was included in Prepaid expenses and other current assets and Other ~~Liabilities~~assets and the cumulative ~~loss~~gain of ~~$14~~$5 million was included in AOCI on the Consolidated Balance Sheets.

The following ~~tables summarize~~table summarizes the impact of the cross-currency swaps to AOCI and the Consolidated Statements of Operations:

	Three Months Ended June 30															Three Months Ended June 30
	2019			2018		2019			2018			2019		2018		2020		2019			2020			2019			2020		2019
Description	Gain/(Loss) Recognized in AOCI					(Gain)/Loss Reclassified from AOCI into Interest Expense in the Consolidated Statements of Operations						(Gain)/Loss Recognized in Interest Expense in the Consolidated Statements of Operations (Amount Excluded from Effectiveness Testing)				Gain/(Loss) Recognized in AOCI					(Gain)/Loss Reclassified from AOCI into Interest Expense in the Consolidated Statements of Operations						(Gain)/Loss Recognized in Interest Expense in the Consolidated Statements of Operations (Amount Excluded from Effectiveness Testing)
	(In millions)															(In millions)
Cross-currency swaps	$	(1	)	$	10	$	(1	)	$	(2	)	$	—	$	—	$	1	$	(1	)	$	(2	)	$	(1	)	$	—	$	—

From time to time, the Company may enter into certain derivative instruments that may not be designated as hedges for accounting purposes, which may include cross-currency swaps, foreign currency forward contracts and commodity derivatives. For cross-currency swaps and foreign currency forward contracts not designated as hedges, the Company uses standard models with market-based inputs. The significant inputs to these models are interest rate curves for discounting future cash flows, and exchange rate curves of the foreign currency for translating future cash flows. In determining the fair value of the commodity derivatives, the significant inputs to valuation models are quoted market prices of similar instruments in active markets. Although these derivatives do not qualify for hedge accounting, Cabot believes that such instruments are closely correlated with the underlying exposure, thus managing the associated risk. The gains or losses from changes in the fair value of derivative instruments that are not accounted for as hedges are recognized in current period earnings.

At both June 30, 2020 and September 30, 2019, the fair value of derivative instruments not designated as hedges were ~~immaterial~~nominal, and these instruments were presented in ~~Accounts payable and accrued liabilities, and~~ Prepaid expenses and other current assets ~~on the Consolidated Balance Sheets. At September 30, 2018, the fair value of derivative instruments not designated as hedges were immaterial~~ and ~~were presented in~~ Accounts payable and accrued liabilities on the Consolidated Balance Sheets.

Cabot owns 100% of a carbon black operating entity in Argentina. Effective July 1, 2018, the operating entity was considered to be functioning in a highly inflationary economy and began using Cabot’s reporting currency, the U.S. dollar, as its functional currency. Since the conversion, all impacts of foreign exchange changes between the reporting currency and Argentine peso are reflected in earnings in the Consolidated Statements of Operations.

~~The Company’s income from operations has not been significantly impacted from this change because the operating entity’s sales and a portion of its raw~~material purchases were already denominated in U.S. dollars. For the three and nine months ended June 30, 2019, the operating entity’s net revenue represented approximately 3% and 2%, respectively, of Cabot’s total net revenue.

The operating entity’s assets and liabilities held in local currency, which consist primarily of cash and cash equivalents, inventories, property, plant and equipment and accounts payable and accrued liabilities, made up less than 2% of Cabot’s total assets and total liabilities as of both June 30, 2019 and September 30, 2018. Changes in the Argentine peso exchange rate will result in foreign currency exchange gains or losses on the operating entity’s peso-denominated monetary assets and liabilities. For the three and nine months ended June 30, 2019, the Company recorded a net gain of less than $1 million and a net loss of $1 million, respectively, within Other (income) expense in the Consolidated Statements of Operations, which reflects the remeasurement of the operating entity’s net monetary liabilities denominated in Argentine pesos using an exchange rate of 42.7 Argentine pesos to the U.S. dollar at June 30, 2019.

~~The Company will continue to monitor the developments in Argentina and their potential impact on the operating entity’s operations or carrying value.~~

Cabot owns 49% of a carbon black operating affiliate in Venezuela, which is accounted for as an equity affiliate, through wholly-owned subsidiaries that carry the investment and receive its dividends. While the operating entity has historically been profitable, it has not been operational in recent periods due to a lack of available raw materials, which is expected to continue for the foreseeable future. As such, in the second quarter of fiscal 2019, the Company performed an impairment analysis and determined that the decrease in fair value of the Venezuelan equity investment is other-than-temporary and that the investment is fully impaired. The Company recorded an impairment charge of $11 million in the second quarter of fiscal 2019, which is included in Other income (expense) within the Consolidated Statement of Operations.

The Company identifies a business as an operating segment if: (i) it engages in business activities from which it may earn revenues and incur expenses; (ii) its operating results are regularly reviewed by the Chief Operating Decision Maker (“CODM”), who is Cabot’s President and Chief Executive Officer, to make decisions about resources to be allocated to the segment and assess its performance; and (iii) it has available discrete financial information. The Company has determined that all of its businesses are operating segments. The CODM reviews financial information at the operating segment level to allocate resources and to assess the operating results and financial performance for each operating segment. Operating segments are aggregated into a reportable segment if the operating segments are determined to have similar economic characteristics and if the operating segments are similar in the following areas: (i) nature of products and services; (ii) nature of production processes; (iii) type or class of customer for their products and services; (iv) methods used to distribute the products or provide services; and (v) if applicable, the nature of the regulatory environment.

~~During the third quarter of fiscal 2019, the~~The Company ~~had four~~has 3 reportable segments: Reinforcement Materials, Performance Chemicals and Purification ~~Solutions and Specialty Fluids.~~Solutions. The Company’s former Specialty Fluids business was ~~divested as~~a separate reporting segment prior to divestiture in the third quarter of ~~June 28, 2019 and since that time Cabot has been organized into the three remaining reportable business segments.~~fiscal 2019.

The Reinforcement Materials segment consists of the rubber blacks and elastomer composites product lines.

The Performance Chemicals segment combines the specialty carbons, fumed metal oxides and aerogel product lines into the Performance Additives business, and combines the specialty compounds and inkjet colorants product lines into the Formulated Solutions business. These businesses are similar in terms of economic characteristics, nature of products, processes, customer class and product distribution methods, and, therefore, have been aggregated into ~~one~~1 reportable segment. The net sales from each of these businesses for the three and nine months ended June 30, ~~2019~~2020 and ~~2018~~2019 were as follows:

	Three Months Ended June 30				Nine Months Ended June 30				Three Months Ended June 30				Nine Months Ended June 30
	2019		2018		2019		2018		2020		2019		2020		2019
	(In millions)								(In millions)
Performance Additives	$	172	$	188	$	518	$	524	$	151	$	172	$	489	$	518
Formulated Solutions		79		86		218		247		69		79		218		218
Performance Chemicals	$	251	$	274	$	736	$	771
Total Performance Chemicals									$	220	$	251	$	707	$	736

The Purification Solutions segment consists of the Company’s activated carbon ~~business, and the Specialty Fluids segment included the cesium formate oil and gas drilling fluids and high-purity fine cesium chemicals product lines.~~business.

Income (loss) ~~from continuing operations~~ before income taxes (“Segment EBIT”) is presented for each reportable segment in the table below. Segment EBIT excludes Interest expense, general unallocated income (expense), unallocated corporate costs, and certain items, meaning items management does not consider representative of on-going operating segment results. In addition, Segment EBIT includes Equity in earnings of affiliated companies, net of tax, the full operating results of a contractual joint venture in Purification Solutions, royalties, Net income attributable to noncontrolling interests, net of tax, and discounting charges for certain Notes receivable, but excludes Interest expense, foreign currency transaction gains and losses, interest income, dividend income, unearned revenue, general unallocated expense and unallocated corporate costs.receivable.

Reinforcement
Materials

Performance
Chemicals

Purification
Solutions

Specialty
Fluids

Segment
Total

Unallocated
and Other⁽¹⁾

Consolidated
Total

(In millions)

Three Months Ended June 30, 2019

Revenues from external customers⁽²⁾

$
461

$
251

$
73

$
13

$
798

$
47

$
845

Income (loss) from continuing operations
   before income taxes⁽³⁾

$
72

$
37

$
1

$
2

$
112

$
(43
)

$
69

Three Months Ended June 30, 2018

Revenues from external customers⁽²⁾

$
466

$
274

$
70

$
12

$
822

$
32

$
854

Income (loss) from continuing operations
   before income taxes⁽³⁾

$
74

$
56

$
(6
)

$
3

$
127

$
(32
)

$
95

Nine Months Ended June 30, 2019

Revenues from external customers⁽²⁾

$
1,363

$
736

$
210

$
56

$
2,365

$
145

$
2,510

Income (loss) from continuing operations
   before income taxes⁽³⁾

$
195

$
111

$
(1
)

$
24

$
329

$
(141
)

$
188

Nine Months Ended June 30, 2018

Revenues from external customers⁽²⁾

$
1,307

$
771

$
206

$
24

$
2,308

$
84

$
2,392

Income (loss) from continuing operations
   before income taxes⁽³⁾

$
215

$
160

$
(6
)

$
(2
)

$
367

$
(351
)

$
16

	Reinforcement Materials			Performance Chemicals		Purification Solutions			Specialty Fluids⁽¹⁾		Segment Total		Unallocated and Other⁽²⁾			Consolidated Total
	(In millions)
Three Months Ended June 30, 2020
Revenues from external customers⁽³⁾	$	197		$	220	$	63		$	—	$	480	$	38		$	518
Income (loss) before income taxes⁽⁴⁾	$	(5	)	$	21	$	2		$	—	$	18	$	(29	)	$	(11	)

Three Months Ended June 30, 2019
Revenues from external customers⁽³⁾	$	461		$	251	$	73		$	13	$	798	$	47		$	845
Income (loss) before income taxes⁽⁴⁾	$	72		$	37	$	1		$	2	$	112	$	(43	)	$	69

Nine Months Ended June 30, 2020
Revenues from external customers⁽³⁾	$	931		$	707	$	186		$	—	$	1,824	$	131		$	1,955
Income (loss) before income taxes⁽⁴⁾	$	103		$	93	$	3		$	—	$	199	$	(148	)	$	51

Nine Months Ended June 30, 2019
Revenues from external customers⁽³⁾	$	1,363		$	736	$	210		$	56	$	2,365	$	145		$	2,510
Income (loss) before income taxes⁽⁴⁾	$	195		$	111	$	(1	)	$	24	$	329	$	(141	)	$	188

	Three Months Ended June 30						Nine Months Ended June 30						Three Months Ended June 30					Nine Months Ended June 30
	2019			2018			2019			2018			2020		2019			2020		2019
	(In millions)												(In millions)
Royalties, the impact of unearned revenue, the removal of 100% of the sales of an equity method affiliate and discounting charges for certain notes receivable	$	(3	)	$	(2	)	$	(9	)	$	(10	)	$	4	$	(3	)	$	2	$	(9	)
Shipping and handling fees		32			34			96			94			22		32			83		96
By-product sales^(a)		18			—			58			—			12		18			46		58
Total	$	47		$	32		$	145		$	84		$	38	$	47		$	131	$	145

	Three Months Ended June 30						Nine Months Ended June 30						Three Months Ended June 30						Nine Months Ended June 30
	2019			2018			2019			2018			2020			2019			2020			2019
	(In millions)												(In millions)
Interest expense	$	(14	)	$	(14	)	$	(43	)	$	(41	)	$	(13	)	$	(14	)	$	(41	)	$	(43	)
Certain items^(a)
Specialty Fluids loss on sale and asset impairment charge (Note D)		(8	)		—			(28	)		—
Equity affiliate investment impairment charge (Note O)		—			—			(11	)		—
Purification Solutions goodwill and long-lived assets impairment charge (Note F)		—			—			—			(254	)
Inventory reserve adjustment (Note F)		—			—			—			(13	)
Global restructuring activities (Note L)		(4	)		(1	)		(15	)		7
Legal and environmental matters and reserves		—			—			(1	)		(6	)		(1	)		—			(51	)		(1	)
Gains (losses) on sale of investments		—			—			—			10
Global restructuring activities (Note K)														(3	)		(4	)		(16	)		(15	)
Employee benefit plan settlements														(2	)		—			(5	)		3
Acquisition and integration-related charges		(1	)		—			(5	)		(1	)		(1	)		(1	)		(3	)		(5	)
Indirect tax settlement credits														—			—			3			—
Specialty Fluids loss on sale and asset impairment charge (Note C)														—			(8	)		(1	)		(28	)
Equity affiliate investment impairment charge														—			—			—			(11	)
Other		(1	)		(2	)		(1	)		(3	)		—			(1	)		(1	)		(4	)
Total certain items, pre-tax		(14	)		(3	)		(61	)		(260	)		(7	)		(14	)		(74	)		(61	)
Unallocated corporate costs^(b)		(14	)		(15	)		(39	)		(45	)		(10	)		(14	)		(32	)		(39	)
General unallocated income (expense)^(c)		—			—			3			(3	)		2			—			1			3
Less: Equity in earnings of affiliated companies, net of tax^(d)		1			—			1			2			1			1			2			1
Total	$	(43	)	$	(32	)	$	(141	)	$	(351	)	$	(29	)	$	(43	)	$	(148	)	$	(141	)

The Company’s segments operate globally. In addition to presenting Revenue from external customers by reportable segment, the following tables further disaggregate ~~Revenue~~Revenues from external customers by geographic region.

Our consolidated financial statements have been prepared in conformity with accounting policies generally accepted in the United States (“GAAP”). The preparation of our financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues, and expenses and related disclosure of contingent assets and liabilities. We consider an accounting estimate to be critical to the financial statements if (i) the estimate is complex in nature or requires a high degree of judgment and (ii) different estimates and assumptions were used, the results could have a material impact on the consolidated financial statements. On an ongoing basis, we evaluate our estimates and the application of our policies. We base our estimates on historical experience, current conditions and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. Our critical accounting policies have not substantially changed from those described in the ~~2018 Form 10-K, other than our method for accounting for revenue recognition which we changed effective October 1, 2018, as described below.~~

We recognize revenue when our customers obtain control of promised goods or services. The revenue recognized is the amount of consideration which we expect to receive in exchange for those goods or services. We derive the majority of our revenues from contracts for the sale of products from our Reinforcement Materials, Performance Chemicals and Purification Solutions segments. Our contracts with customers are generally for products only and do not include other performance obligations. Generally, we consider purchase orders, which in some cases are governed by master supply agreements, to be contracts with customers. The transaction price as specified on the purchase order or sales contract is considered the standalone selling price for each distinct product. To determine the transaction price at the time when revenue is recognized, we evaluate whether the price is subject to adjustments, such as for returns, discounts or volume rebates, which are stated in the customer contract, to determine the net consideration to which we expect to be entitled. Revenue from product sales is recognized based on a point in time model when control of the product is transferred to the customer, which typically occurs upon shipment or delivery of the product to the customer and title, risk and rewards of ownership have passed to the customer. ~~Payment terms typically range from zero to ninety days~~.

Shipping and handling activities that occur after the transfer of control to the customer are billed to customers and are recorded as sales revenue, as we consider these to be fulfillment costs. Shipping and handling costs are expensed in the period incurred and included in Cost of sales within the Consolidated Statement of Operations. Taxes collected on sales to customers are excluded from the transaction price.

We generally provide a warranty that our products will substantially conform to the identified specifications. Our liability typically is limited to either a credit equal to the purchase price or replacement of the non-conforming product. Returns under warranty have historically been immaterial.

Revenue in the Specialty Fluids segment arose primarily from the rental of cesium formate. This revenue was recognized throughout the rental period based on the contracted rental terms. Customers were also billed and revenue was recognized, typically at the end of the rental period, for cesium formate product that was not returned. We also generated revenues from cesium formate sold outside of the rental process and from the sale of fine cesium chemicals. This revenue was recognized when control of the product transferred to the customer, which was typically upon delivery of the product.

~~As permitted by the revenue recognition standard,~~ ~~Revenue from Contracts with Customers~~, when the period of time between the transfer of control of the goods and the time the customer pays for the goods is one year or less, we do not consider there to be a significant financing component associated with the contract.2019 10-K.

Refer to the discussion under the headings “Recently Adopted Accounting Standards” and “Recent Accounting Pronouncements” in Note B of our Notes to the Consolidated Financial Statements.

Cabot was organized into four reportable business segments through June 28, 2019: Reinforcement Materials, Performance Chemicals, Purification Solutions and Specialty Fluids. The Specialty Fluids business was divested as of June 28, 2019 and since that time Cabot has been organized into the three remaining reportable business segments. Cabot is also organized for operational purposes into three geographic regions: the Americas; Europe, Middle East and Africa; and Asia Pacific. The ~~discussions~~discussion of our results of operations for the periods presented reflect these structures. In October 2018, the Company realigned its business reporting structure under the Performance Chemicals segment and now combines the specialty carbons, fumed metal oxides and aerogel product lines into the Performance Additives business, and the specialty compounds and inkjet product lines into the Formulated Solutions business. Prior period Performance Chemicals Segment revenue results have been recast to reflect the realignment.

Our analysis of our financial condition and operating results should be read with our consolidated financial statements and accompanying notes.

When discussing our results of operations, we use several terms as described below.

The term “product mix” refers to the mix of types and grades of products sold or the mix of geographic regions where products are sold, and the positive or negative impact this has on the revenue or profitability of the business and/or segment.

Our discussion under the heading “(Provision) Benefit for Income Taxes and Reconciliation of Effective Tax Rate to Operating Tax Rate” includes a discussion and reconciliation of our ~~historical and expected~~ “effective tax rate” and our “operating tax rate” ~~and includes a reconciliation~~for the periods presented, as well as management’s projection of our operating tax rate range for the ~~two rates.~~full fiscal year. Our operating tax rate is a non-GAAP financial measure and should not be considered as an alternative to our effective tax rate, the most comparable GAAP financial measure. In calculating our operating tax rate, we exclude discrete tax items, which include: (i) unusual or infrequent items, such as a significant release or establishment of a valuation allowance, (ii) items related to uncertain tax positions, such as the tax impact of audit settlements, interest on tax reserves, and the release of tax reserves from the expiration of statutes of limitations, and (iii) other discrete tax items, such as the tax impact of legislative changes and, on a quarterly basis, the timing of losses in certain jurisdictions and the cumulative rate adjustment, if applicable. We also exclude the tax impact of certain items, as defined below in the discussion of Total segment EBIT, on both operating income and the tax provision. When the tax impact of a certain item is also a discrete tax item, it is classified as a certain item for our definition of operating tax rate. Our definition of the operating tax rate may not be comparable to the definition used by other companies. Management believes that this non-GAAP financial measure is useful supplemental information because it helps our investors compare our tax rate year to year on a consistent basis and to understand what our tax rate on current operations would be without the impact of these items.

Our discussion under the heading “Third Quarter and First Nine Months of Fiscal ~~2019~~2020 versus Third Quarter and First Nine Months of Fiscal ~~2018—~~2019—By Business Segment” includes a discussion of Total segment EBIT, which is a non-GAAP financial measure defined as Income (loss) ~~from continuing operations~~ before income taxes and equity in earnings from affiliated companies less certain items and other unallocated items. Our Chief Operating Decision Maker, who is our President and Chief Executive Officer, uses segment EBIT to evaluate the operating results of each segment and to allocate resources to the segments. We believe Total segment EBIT, which reflects the sum of EBIT from our ~~four~~ reportable segments, provides useful supplemental information for our investors as it is an important indicator of our operational strength and performance, allows investors to see our results through the eyes of management, and provides context for our discussion of individual business segment performance. Total segment EBIT should not be considered an alternative for Income (loss) ~~from continuing operations~~ before income taxes and equity in earnings of affiliated companies, which is the most directly comparable GAAP financial measure. A reconciliation of Total segment EBIT to Income (loss) ~~from continuing operations~~ before income taxes and equity in earnings of affiliated companies is provided under the heading “Third ~~Quarter~~quarter of Fiscal ~~2019~~2020 versus Third ~~Quarter~~quarter of Fiscal ~~2018—~~2019—By Business Segment”. Investors should consider the limitations associated with this non-GAAP measure, including the potential lack of comparability of this measure from one company to another.

In calculating Total segment EBIT, we exclude from our Income (loss) ~~from continuing operations~~ before income taxes and equity in earnings of affiliated companies (i) items of expense and income that management does not consider representative of our fundamental on-going segment results, which we refer to as “certain items”, and (ii) items that, because they are not controlled by the business segments and primarily benefit corporate objectives, are not allocated to our business segments, such as interest expense and other corporate costs, which include unallocated corporate overhead expenses such as certain corporate salaries and headquarter expenses, plus costs related to special projects and initiatives, which we refer to as “other unallocated items”. Management believes excluding the items identified as certain items facilitates operating performance comparisons from period to period by eliminating differences caused by the existence and timing of certain expense and income items that would not otherwise be apparent on a GAAP basis and also facilitates an evaluation of our operating performance without the impact of these costs or benefits. The items of income and expense that we ~~have excluded~~exclude from Total segment EBIT ~~as applicable,~~ but that are included in our GAAP Income (loss) ~~from continuing operations~~ before income taxes and equity in earnings of affiliated companies, as applicable in a particular reporting period, include, but are ~~described below.~~not limited to, the following:

During the third quarter of fiscal ~~2019,~~2020, Income (loss) ~~from continuing operations~~ before income taxes and equity in earnings of affiliated companies decreased compared to the third quarter of fiscal ~~2018.~~2019. The decrease primarily reflects the decrease in Total Segment EBIT of $15 million driven by lower margins in Performance Chemicals due to the unfavorable impact to margins in China and Europe from a combination of weaker pricing due to softening automotive production and a less favorable product and regional mix. The decrease also reflects the $8 million loss on sale of the Specialty Fluids business recorded$94 million. Total Segment EBIT in the third quarter of fiscal 2019 included $2 million related to our Specialty Fluids business, which we divested in the third quarter of fiscal 2019. Excluding the impact from the divestiture of our Specialty Fluids business, Total Segment EBIT decreased $92 million driven by lower volumes in all segments and lower margins in Reinforcement Materials and Performance Chemicals, partially offset by lower fixed costs due to cost reduction activities.

In December 2019, a novel coronavirus disease (“COVID-19”) was first reported and in January 2020, the World Health Organization (“WHO”) declared it a Public Health Emergency of International Concern. On March 11, 2020, the WHO characterized COVID-19 as a global pandemic, due to the continued increase in the number of cases and affected countries. In an effort to contain COVID-19 or slow its spread, governments around the world enacted various measures, including orders to close all businesses not deemed “essential,” isolate residents in their places of residence, and practice social distancing when engaging in essential activities. The coronavirus pandemic and the associated containment efforts have had a serious adverse impact on the economy, the severity and duration of which are uncertain. Government stabilization efforts will only partially mitigate the consequences.

The coronavirus pandemic has adversely affected and is expected to continue to adversely affect, our business, results of operations and cash flows. While most of our facilities have remained open given the “essential” status of many of our end-markets, such as infrastructure, agriculture and pharmaceutical production, we have operated at low production and utilization rates beginning late in the second fiscal quarter due to declined demand from the halt of customer operations within the tire and automotive sectors. Beginning during our second fiscal quarter, as the virus spread in China, we experienced volume declines principally in our Reinforcement Materials segment as operations at many of our customers’ plants in China were completely or partially curtailed. As the COVID-19 pandemic began to further spread around the globe, on the recommendation or mandate of public health officials, a number of our key customers, notably most automotive and tire manufacturers in the Americas and Europe, temporarily closed their manufacturing operations beginning in March 2020. As a result, in the third fiscal quarter, we experienced further volume declines in our Reinforcement Materials segment as well as volume declines and weaker product mix in our Performance Chemicals and Purification Solutions segments. In the third quarter, we also operated at significantly lower manufacturing levels at many of our plants and temporarily suspended operations or idled production lines at certain facilities to comply with government mandates to cease operations. Beginning at the end of March, the domestic automotive and tire end-markets in China began to restart operations, and in the months of May and June 2020, our major tire customers in the Americas and Europe slowly restarted their operations although, at lower than normal operating rates. Along with these improvements, volumes in our Reinforcement Materials segment improved from May to June, and continued to improve in July. Based on volumes to date in the fourth quarter, we expect improved results in our Reinforcement Materials segment for the quarter, as well as improved production and utilization rates, although not to normal levels. We also expect volumes in our Performance Chemicals segment to improve modestly in the fourth fiscal quarter from those in the third fiscal quarter. Despite certain indications that demand for our products is improving from the low demand levels we experienced in our third fiscal quarter, because the duration and scope of the COVID-19 pandemic continue to be uncertain we are unable to predict with certainty the speed and shape of a recovery to more normal customer demand levels for our products or more normal manufacturing operating levels at our facilities.

To date, the coronavirus pandemic has not affected our ability to adequately staff and maintain our operations and we have been able to continue to supply our customers around the globe. However, a prolonged duration of the pandemic could materially impair our ability to do so in the future. This is, particularly the case as the spread of the virus increases in certain geographies and with the possibility that government authorities may impose further mandatory closures, extend work-from-home orders and social distancing protocols, and seek voluntary facility closures and impose other restrictions to mitigate the further spread of the virus. Further, because we reduced inventory to respond to an unusually low customer demand environment, a prolonged duration of any future interruption in our manufacturing operations could impair our ability to meet customer demand in the future.

We took a number of actions during the third fiscal quarter to mitigate the impact of the coronavirus on our cash flow and results of operations and financial condition. While manufacturing operations were curtailed, we managed inventory levels, and reduced our manufacturing costs. We also reduced discretionary spending and net working capital with lower raw material costs and reductions in our accounts receivable and inventories. While our liquidity position remains strong, effective June 8, 2020, we amended our revolving credit agreements to temporarily increase the maximum leverage ratio permitted under those agreements to provide incremental headroom in light of the uncertainty in demand due to the coronavirus pandemic, as described in detail below under the heading “Cash Flow and Liquidity”. In addition, we have reduced our planned capital expenditures in fiscal 2020 to approximately $200 million, prioritizing growth projects in our Performance Additives business as well as necessary sustaining and compliance projects. We also suspended our share repurchases and do not anticipate repurchasing shares for the remainder of the fiscal year.

We expect COVID-19 to continue to have an adverse impact on our revenue as well as our overall profitability and may lead to an increase in inventory reserves, allowances for doubtful accounts, and valuation allowances on certain of our deferred tax assets. Additionally, if the business impacts of the COVID-19 pandemic carry on for an extended period, it could cause us to recognize impairments for certain long-lived assets including goodwill, intangible assets or property, plant and equipment.

Third ~~Quarter~~quarter of Fiscal ~~2019~~2020 versus Third ~~Quarter~~quarter of Fiscal ~~2018—~~2019—Consolidated

	Three Months Ended June 30				Nine Months Ended June 30				Three Months Ended June 30				Nine Months Ended June 30
	2019		2018		2019		2018		2020		2019		2020		2019
	(In millions)								(In millions)
Net sales and other operating revenues	$	845	$	854	$	2,510	$	2,392	$	518	$	845	$	1,955	$	2,510
Gross profit	$	170	$	197	$	514	$	561	$	69	$	170	$	363	$	514

~~The $9 million decrease in net~~Net sales in the third quarter of fiscal ~~2019~~2020 decreased by $327 million compared to the third quarter of fiscal ~~2018~~2019. The third quarter of fiscal 2019 included $13 million of revenue for our Specialty Fluids business. The remaining $314 million decline in net sales was primarily driven by lower volumes ($221 million), a less favorable price and product mix (combined $65 million), and the unfavorable impact from foreign currency translation ($3218 million) ~~and~~. The lower volumes ~~($15 million), partially offset~~were driven by ~~a more~~our Reinforcement Materials segment due to weaker demand related to declines in automotive and tire production resulting from the impact of the COVID-19 pandemic. Declines in automotive production also adversely impacted volumes in Specialty Carbons. The less favorable price and product mix ~~(combined $22 million)~~was due to lower prices from lower feedstock costs that are passed through to our customers in the Reinforcement Materials segment and unfavorable product mix in the Performance Chemicals segment due to more competitive pricing and weaker product mix in the fumed metal oxides product line in China and Europe and the ~~impact of~~less favorable product mix in the ~~change~~specialty carbons product line from lower demand in ~~classification of by-product sales, effective October 1, 2018, from a reduction of Cost of sales to an inclusion in~~ automotive applications.

Net sales ~~and other operating revenues ($18 million). For~~in the first nine months of fiscal ~~2019, net sales increased $118~~2020 declined by $555 million compared to the first nine months of fiscal ~~2018~~2019. The first nine months of fiscal 2019 included $56 million of revenue for our Specialty Fluids business. The remaining $499 million decline in net sales was driven by lower volumes primarily ~~due to~~in Reinforcement Materials and Purification Solutions ($285 million), a ~~more~~less favorable price and product mix (combined ~~$146~~$162 million) ~~predominantly in Reinforcement Materials, partially offset by~~, and the unfavorable impact from foreign currency translation ($7738 million). The less favorable price and product mix was due to lower prices in Reinforcement Materials due to the pass through of lower feedstock costs and a weaker product mix in the Performance Chemicals segment due to the more competitive pricing and weaker product mix in the fumed metal oxides product line in China and Europe and the less favorable product mix in our specialty carbons product line from lower demand in automotive applications. The lower volumes were driven by our Reinforcement Materials segment due to weak automotive and tire demand and the impact of the COVID-19 pandemic on demand. The lower volumes in the Purification Solutions segment was due to lower sales in mercury removal and other industrial gas and air applications, due to historically low natural gas prices, and lower ~~volumes ($15 million). Net sales were also impacted by the change in classification of by-product sales, effective October 1, 2018,~~demand for automotive applications related to impacts from ~~a reduction of Cost of sales to an inclusion in Net sales and other operating revenues ($58 million).~~COVID-19.

Gross profit decreased by ~~$27~~$101 million in the third quarter of fiscal ~~2019~~2020 compared to the third quarter of fiscal ~~2018,~~2019. Excluding the impact of the divestiture of our Specialty Fluids business, the gross profit decline was primarily due to lower volumes from Reinforcement Materials due to declining demand from weaker automotive and ~~lower unit margins~~tire production related to the impacts of the COVID-19 pandemic on demand. Gross profit decreased by $151 million in ~~Performance Chemicals. Lower volumes and lower unit margins were caused by softer automotive production and less favorable mix. For~~ the first nine months of fiscal ~~2019,~~2020 compared to the first nine months of fiscal 2019. Excluding the impact of the divestiture of our Specialty Fluids business, the gross profit ~~decreased by $47 million~~decline was primarily due to lower volumes in Reinforcement Materials and Purification Solutions and lower unit margins in ~~Reinforcement Materials and~~the Performance Chemicals ~~partially offset by higher project activity from the Specialty Fluids segment.~~segments.

Selling and administrative expenses decreased by ~~$9 million and $15~~$13 million in the third quarter of fiscal 2020 compared to the same period of fiscal 2019, primarily due to a decrease in the accrual for incentive compensation and other cost reduction activities in the current fiscal year. Selling and administrative expense increased by $22 million in the first nine months of fiscal ~~2019~~2020 compared to the same ~~periods~~period of fiscal ~~2018,~~2019, primarily due to ~~lower~~the $50 million charge related to a legal settlement recorded during the second quarter of fiscal 2020, partially offset by a decrease in the accrual for incentive compensation and ~~discretionary spending, partially offset by restructuring charges.~~other cost reduction activities in the current fiscal year.

Research and technical expenses decreased by $1$3 million and $6 million in ~~both~~ the third quarter ~~of fiscal 2019~~ and the first nine months of fiscal ~~2019~~2020, respectively, compared to the same periods of fiscal ~~2018,~~2019, due to ~~efforts to reduce costs~~cost reduction activities in the current fiscal year.

	Three Months Ended June 30						Nine Months Ended June 30						Three Months Ended June 30						Nine Months Ended June 30
	2019			2018			2019			2018			2020			2019			2020			2019
	(In millions)												(In millions)
Interest and dividend income	$	2		$	2		$	6		$	8		$	1		$	2		$	7		$	6
Interest expense	$	(14	)	$	(14	)	$	(43	)	$	(41	)	$	(13	)	$	(14	)	$	(41	)	$	(43	)
Other income (expense)	$	—		$	1		$	(6	)	$	13		$	(3	)	$	—		$	(6	)	$	(6	)

Interest and dividend income ~~remained consistent in the third quarter of fiscal 2019 compared to the same period of fiscal 2018. For the nine months ended June 30, 2019, Interest and dividend income~~ decreased ~~by $2 million compared to the same period for fiscal 2018 primarily due to lower cash balances.~~

Interest expense remained consistent in the third quarter of fiscal 2019 compared to the same period of fiscal 2018. For the nine months ended June 30, 2019, Interest expense increased by $2 million compared to the same period of fiscal 2018 primarily due to higher commercial paper balances and higher interest rates.

~~Other income (expense) changed by~~ $1 million in the third quarter of fiscal 2020 compared to the same period of fiscal 2019, primarily due to lower interest rates. For the nine months ended June 30, 2020, Interest and dividend income increased $1 million primarily due to interest earned from higher interest rates on cash deposits in South America.

Interest expense decreased $1 million in the third quarter of fiscal 2020 compared to the same period of fiscal 2019 primarily due to lower interest rates. For the nine months ended June 30, 2020, interest expense decreased $2 million as compared to the same period of fiscal 2019, primarily due to lower average debt balances.

Other income (expense) changed by $3 million in the third quarter of fiscal 2020 compared to the third quarter of fiscal ~~2018,~~2019, primarily due to ~~higher pension costs. For~~ the ~~nine months ended June 30, 2019,~~unfavorable impact of foreign currency translation. Other income (expense) ~~changed by $19 million~~remained consistent in the first nine months of fiscal 2020 compared to the same period of fiscal 2018 due to the impairment charge related to our investment in our Venezuelan equity affiliate in the second quarter of fiscal 2019 and a gain on the sale of cost method investments in fiscal 2018 that did not reoccur in fiscal 2019, partially offset by the favorable impact of foreign currency translation.2019.

(Provision) Benefit for Income Taxes and Reconciliation of Effective Tax Rate to Operating Tax Rate

	Three Months Ended June 30						Nine Months Ended June 30						Three Months Ended June 30						Nine Months Ended June 30
	2019			2018			2019			2018			2020			2019			2020			2019
	(Dollars in millions)												(Dollars in millions)
(Provision) benefit for income taxes	$	(30	)	$	4		$	(43	)	$	(194	)	$	5		$	(30	)	$	(9	)	$	(43	)

Effective tax rate		43	%		(3	)%		23	%		1202	%		51	%		43	%		17	%		23	%
Impact of discrete tax items⁽¹⁾:
Unusual or infrequent items		(22	)%		3	%		3	%		(1143	)%		—	%		(22	)%		11	%		3	%
Items related to uncertain tax positions		—	%		(1	)%		2	%		(13	)%		(27	)%		—	%		16	%		2	%
Other discrete tax items		4	%		23	%		—	%		136	%		11	%		4	%		3	%		—	%
Impact of certain items		(2	)%		(1	)%		(5	)%		(161	)%		(6	)%		(2	)%		(18	)%		(5	)%
Operating tax rate		23	%		21	%		23	%		21	%		29	%		23	%		29	%		23	%

For fiscal year ~~2019,~~2020, the ~~Effective tax rate and~~ Operating tax rate ~~are~~is expected to be ~~23%, as shown~~ in the ~~table below.~~

range of 29% to 30%. We are not providing a forward-looking reconciliation of the operating tax rate range with an effective tax rate range because, without unreasonable effort, we are unable to predict with reasonable certainty the matters we would allocate to “certain items,” including unusual gains and losses, costs associated with future restructurings, acquisition-related expenses and litigation outcomes. These items are uncertain, depend on various factors, and could have a material impact on the effective tax rate in future periods.

We file U.S. federal and state and non-U.S. income tax returns in jurisdictions with varying statutes of limitations. We are under audit in a number of jurisdictions. It is possible that some of these audits will be resolved in fiscal ~~2019~~2020 and could impact our anticipated effective tax rate. We have filed our tax returns in accordance with the tax laws, in all material respects, in each jurisdiction and maintain tax reserves for uncertain tax positions.

On December 22, 2017, the U.S. enacted significant changes to federal income tax law affecting us, including a permanent reduction of the U.S. corporate income tax rate from 35% to 21%, effective January 1, 2018, as well as a 100% dividend received deduction for foreign dividends. Although the passage of the Act reduced the U.S. tax rate and effectively created a participation exemption regime for foreign earnings, certain other aspects of the new legislation, including in particular, immediate U.S. taxation of global intangible low-taxed income (“GILTI”) earned by foreign subsidiaries, will have a negative impact on earnings and this is the primary driver of the increase in the Company’s operating tax rate. In transitioning to this participation exemption regime, we were also subject, during our fiscal 2018, to a one-time tax on the deemed repatriation of certain foreign ~~earnings.~~

Equity in Earnings of Affiliated Companies and Net Income (Loss) Attributable to Noncontrolling Interests

	Three Months Ended June 30				Nine Months Ended June 30				Three Months Ended June 30				Nine Months Ended June 30
	2019		2018		2019		2018		2020		2019		2020		2019
	(In millions)								(In millions)
Equity in earnings of affiliated companies, net of tax	$	1	$	—	$	1	$	2	$	1	$	1	$	2	$	1
Net income (loss) attributable to noncontrolling interests, net of tax	$	8	$	11	$	22	$	31	$	1	$	8	$	10	$	22

~~Earnings at each of our equity affiliates, net of tax, did not change materially in the third quarter of fiscal 2019 compared to the same period of fiscal 2018.~~ Equity in earnings of affiliated companies, net of tax, ~~decreased~~remained consistent in the third quarter of fiscal 2020 compared to the same period of fiscal 2019. Equity in earnings of affiliated companies, net of tax, increased by $1 million in the first nine months of fiscal ~~2019~~2020 compared to the same period of fiscal ~~2018, primarily due~~2019. The $2 million of income in the first nine months of fiscal 2020 relates to ~~lower earnings~~income from our ~~Venezuelan~~ equity ~~affiliate.~~affiliates in India and Mexico. In fiscal 2019, this income was consistent with fiscal 2020, but also included losses from our equity affiliate in Venezuela, which has since been impaired.

Net income (loss) attributable to noncontrolling interests, net of tax, decreased by $3$7 million in the third quarter of fiscal 2020 and $9$12 million in the first nine months of fiscal ~~2019~~2020 compared to the same periods of fiscal ~~2018,~~2019, primarily due to the lower profitability from our joint ventures in ~~China.~~China and Czech Republic.

In the third quarter and first nine months of fiscal ~~2019,~~2020, we reported net income (loss) attributable to Cabot Corporation of $(6) million and $34 million or $(0.12) and $0.59 per diluted common share, respectively. This compares to net income (loss) attributable to Cabot Corporation of $32 million and $124 million, or $0.55 and $2.08 per diluted common share, ~~respectively. This compares to net income (loss) attributable to Cabot Corporation of $88 million and ($207) million, or $1.40 and ($3.36) per diluted common share,~~ respectively, in the third quarter and first nine months of fiscal ~~2018.~~2019. The net loss in the third quarter of fiscal 2020 is primarily due to lower Segment EBIT due to the impact of the COVID-19 pandemic on demand. The lower net income in the first nine months of fiscal ~~2018 was driven by~~2020 is primarily due to lower Segment EBIT due to the ~~Purification Solutions asset impairment~~impact of the COVID-19 pandemic on demand and a $50 million charge related to a legal settlement recorded in the second quarter of ~~$224 million after-tax. In addition,~~fiscal 2020.

The net income (loss) attributable to Cabot Corporation for the third quarter and first nine months of fiscal ~~2018 were impacted by a tax charge of $185 million recorded~~2019 includes impairment charges associated with our divested Specialty Fluids business which did not recur in ~~connection with the enactment of the Act.~~fiscal 2020.

Third ~~Quarter~~quarter of Fiscal ~~2019~~2020 versus Third ~~Quarter~~quarter of Fiscal ~~2018—~~2019—By Business Segment

Income (loss) ~~from continuing operations~~ before income taxes and equity in earnings of affiliated companies, certain items, other unallocated items, and Total segment EBIT for the three and nine months ended June 30, ~~2019~~2020 and ~~2018~~2019 are set forth in the table below. The details of certain items and other unallocated items are shown below and in Note PN of our Notes to the Consolidated Financial Statements.

	Three Months Ended June 30						Nine Months Ended June 30						Three Months Ended June 30						Nine Months Ended June 30
	2019			2018			2019			2018			2020			2019			2020			2019
	(In millions)												(In millions)
Income (loss) from continuing operations before income taxes and equity in earnings of affiliated companies	$	69		$	95		$	188		$	16
Income (loss) before income taxes and equity in earnings of affiliated companies													$	(11	)	$	69		$	51		$	188
Less: Certain items		(14	)		(3	)		(61	)		(260	)		(7	)		(14	)		(74	)		(61	)
Less: Other unallocated items		(29	)		(29	)		(80	)		(91	)		(22	)		(29	)		(74	)		(80	)
Total segment EBIT	$	112		$	127		$	329		$	367		$	18		$	112		$	199		$	329

In the third quarter of fiscal ~~2019,~~2020, Income (loss) ~~from continuing operations~~ before income taxes and equity in earnings of affiliated companies decreased by ~~$26~~$80 million and Total segment EBIT decreased by ~~$15~~$94 million. ~~These changes were due~~Included in the third quarter of fiscal 2019 is $2 million of EBIT related to our Specialty Fluids business, which we divested in the third quarter of fiscal 2019. Excluding the Specialty Fluids impact, Total Segment EBIT decreased $92 million. The decrease in Total segment EBIT is driven by lower volumes ~~($10 million)~~in each of our three segments and ~~lower unit margins ($11 million) driven by the Reinforcement Materials and Performance Chemicals segments, partially offset by lower fixed costs ($6 million) across all segments. The~~ lower margins in Reinforcement Materials and Performance Chemicals, partially offset by lower fixed costs. Lower volumes in Reinforcement Materials ($75 million) were primarily due to weaker automotive and tire demand and lower volumes in Performance Chemicals ($7 million) were primarily due to weaker automotive demand, in each case related to the impacts from the COVID-19 pandemic. Lower volumes in Purification Solutions ($8 million) were due to weaker demand in mercury removal applications and the impact of the COVID-19 pandemic on the demand for automotive applications. Lower margins in Reinforcement Materials ($17 million) were primarily due to the rapid decline of global feedstock costs, which resulted in a temporary pricing and cost mismatch, and regional mix, partially offset by lower raw material costs. Lower margins in Performance Chemicals ($9 million) were primarily due to lower pricing in our fumed metal oxides product line and a less favorable product mix in our specialty carbons product line. Lower fixed costs ($32 million) were driven by lower production volumes and other cost reduction actions.

In the ~~unfavorable impact to margins in China and Europe from weaker pricing due to softening automotive production. In addition, the decrease in~~first nine months of fiscal 2020, Income (loss) ~~from continuing operations~~ before income taxes and equity in earnings of affiliated companies ~~reflects~~decreased $137 million and total Segment EBIT decreased by $130 million. Included in the $8first nine months of fiscal 2019 is $24 million ~~loss on sale~~ of ~~the~~EBIT related to our Specialty Fluids business, ~~recorded~~which we divested in the third quarter of fiscal 2019.

In Excluding the ~~first nine months of fiscal 2019, Income (loss) from continuing operations before income taxes and equity in earnings of affiliated companies increased by $172 million and~~Specialty Fluids impact, Total segment EBIT decreased ~~by $38~~$106 million. The increase in Income (loss) from continuing operations before income taxes and equity in earnings of affiliated companies reflects the Purification Solutions asset impairment charges recorded in the second quarter of fiscal 2018 ($254 million) that did not reoccur in fiscal 2019 and the decrease in expense related to other unallocated items ($11 million), partially offset by the Specialty Fluids loss on sale and asset impairment charge ($28 million) and an impairment charge related to our Venezuelan equity affiliate ($11 million) recorded in the second quarter of fiscal 2019 and higher restructuring charges related to the Purification Solutions transformation plan. The decrease in Total segment EBIT was ~~due to~~driven by lower ~~unit margins ($32 million), primarily~~volumes in Reinforcement Materials and Purification Solutions and lower margins in Performance Chemicals, partially offset by lower fixed costs. Lower volumes in Reinforcement Materials ($101 million) were primarily due to weaker automotive and tire demand and the impacts of the COVID-19 pandemic on demand while lower volumes in Purification Solutions ($920 million) ~~which~~were due to lower volumes in mercury removal applications and the impact of the COVID-19 pandemic on demand for automotive applications. Lower fixed costs ($30 million) were driven by ~~Performance Chemicals.~~lower production volumes and other cost reduction actions. The ~~lower unit margins were primarily driven by weaker China~~decrease in Income (loss) before income taxes and ~~Europe pricing due~~equity earnings of affiliated companies also reflects a $50 million charge related to ~~softening automotive production.~~a legal settlement entered into during the nine months of fiscal 2020.

Details of the certain items for the third quarter and first nine months of fiscal ~~2019~~2020 and fiscal ~~2018~~2019 are as follows:

	Three Months Ended June 30						Nine Months Ended June 30						Three Months Ended June 30						Nine Months Ended June 30
	2019			2018			2019			2018			2020			2019			2020			2019
	(In millions)												(In millions)
Specialty Fluids loss on sale and asset impairment charge (Note D)	$	(8	)	$	—		$	(28	)	$	—
Equity affiliate investment impairment charge (Note O)		—			—			(11	)		—
Purification Solutions goodwill and long-lived assets impairment charge (Note F)		—			—			—			(254	)
Inventory reserve adjustment (Note F)		—			—			—			(13	)
Global restructuring activities (Note L)		(4	)		(1	)		(15	)		7
Legal and environmental matters and reserves		—			—			(1	)		(6	)	$	(1	)	$	—		$	(51	)	$	(1	)
Gains (losses) on sale of investments		—			—			—			10
Global restructuring activities (Note K)														(3	)		(4	)		(16	)		(15	)
Employee benefit plan settlements														(2	)		—			(5	)		3
Acquisition and integration-related charges		(1	)		—			(5	)		(1	)		(1	)		(1	)		(3	)		(5	)
Specialty Fluids loss on sale and asset impairment charge (Note C)														—			(8	)		(1	)		(28	)
Indirect tax settlement credits														—			—			3			—
Equity affiliate investment impairment charge														—			—			—			(11	)
Other		(1	)		(2	)		(1	)		(3	)		—			(1	)		(1	)		(4	)
Total certain items, pre-tax		(14	)		(3	)		(61	)		(260	)		(7	)		(14	)		(74	)		(61	)
Tax-related certain items:
Tax impact of certain items		1			(2	)		4			28			2			1			12			4
Discrete tax items		(14	)		26			10			(164	)		2			(14	)		15			10
Total tax-related certain items		(13	)		24			14			(136	)		4			(13	)		27			14
Total certain items, after tax	$	(27	)	$	21		$	(47	)	$	(396	)	$	(3	)	$	(27	)	$	(47	)	$	(47	)

The tax impact of certain items is determined by (1) starting with the current and deferred income tax expense or benefit included in Net income (loss) attributable to Cabot Corporation, and (2) subtracting the tax expense or benefit on “adjusted earnings”. Adjusted earnings is defined as the pre-tax income attributable to Cabot Corporation excluding certain items. The tax expense or benefit on adjusted earnings is calculated by applying the operating tax rate, as defined under the heading “Definition of Terms and Non-GAAP Financial Measures”, to adjusted earnings.

	Three Months Ended June 30						Nine Months Ended June 30						Three Months Ended June 30						Nine Months Ended June 30
	2019			2018			2019			2018			2020			2019			2020			2019
	(In millions)												(In millions)
Interest expense	$	(14	)	$	(14	)	$	(43	)	$	(41	)	$	(13	)	$	(14	)	$	(41	)	$	(43	)
Unallocated corporate costs		(14	)		(15	)		(39	)		(45	)		(10	)		(14	)		(32	)		(39	)
General unallocated income (expense)		—			—			3			(3	)		2			—			1			3
Less: Equity in earnings of affiliated companies, net of tax		1			—			1			2			1			1			2			1
Total other unallocated items	$	(29	)	$	(29	)	$	(80	)	$	(91	)	$	(22	)	$	(29	)	$	(74	)	$	(80	)

A discussion of items that we refer to as “other unallocated items” can be found under the heading “Definition of Terms and Non-GAAP Financial Measures”. The balances of unallocated corporate costs are primarily comprised of expenditures related to managing a public company that are not allocated to the segments and corporate business development costs related to ongoing corporate projects. The balances of General unallocated income (expense) consist of gains (losses) arising from foreign currency transactions, net of other foreign currency risk management activities, the profit or loss related to the corporate adjustment for unearned revenue, and the impact of including the full operating results of a contractual joint venture in Purification Solutions segment EBIT.

Total other unallocated items remained consistent in the third quarter of fiscal 2019 as compared to the same period in fiscal 2018. Within Total other unallocated items, Unallocated corporate costs decreased $1 million in the third quarter of fiscal 2019 as compared to the same period in fiscal 2018. Equity in earnings of affiliated companies, net of tax, did not change materially in the third quarter of fiscal 2019 compared to the same period of fiscal 2018.

Total other unallocated items changed by $11 million in the first nine months of fiscal 2019 as compared to the same period in fiscal 2018 primarily due to the change in General unallocated income (expense) from lower interest income, and a decrease in Unallocated corporate costs for corporate projects and lower incentive compensation.

Sales and EBIT for Reinforcement Materials for the third quarter and first nine months of fiscal ~~2019~~2020 and ~~fiscal 2018~~2019 were as follows:

	Three Months Ended June 30				Nine Months Ended June 30				Three Months Ended June 30					Nine Months Ended June 30
	2019		2018		2019		2018		2020			2019		2020		2019
	(In millions)								(In millions)
Reinforcement Materials Sales	$	461	$	466	$	1,363	$	1,307	$	197		$	461	$	931	$	1,363
Reinforcement Materials EBIT	$	72	$	74	$	195	$	215	$	(5	)	$	72	$	103	$	195

Sales in Reinforcement Materials decreased by $5$264 million in the third quarter of fiscal ~~2019~~2020 compared to the same period of fiscal ~~2018,~~2019, primarily due to lower volumes ($195 million), a less favorable price and product mix (combined $56 million), and the unfavorable impact from foreign currency translation ($1913 million) ~~and~~. The lower volumes ~~($8 million), partially offset by more favorable pricing ($22 million).~~were primarily due to weaker automotive and tire demand resulting from the impact of the COVID-19 pandemic. The less favorable pricing was primarily due to ~~benefits from calendar year 2019 customer agreements and partially offset by~~the pass-through of lower ~~spot pricing in China.~~feedstock prices.

In the first nine months of fiscal ~~2019,~~2020, sales in Reinforcement Materials ~~increased~~decreased by ~~$56~~$432 million when compared to the first nine months of fiscal ~~2018.~~2019. The ~~increase~~decrease was ~~principally~~primarily driven by lower volumes ($273 million), a ~~more~~less favorable price and product mix (combined ~~$107~~$133 million), ~~partially offset by~~and the unfavorable impact from foreign currency translation ($4726 million) ~~and~~. The lower volumes ~~($5 million).~~were primarily due to weaker automotive and tire demand and the impacts of the COVID-19 pandemic on demand. The ~~more~~less favorable price and product mix ~~impact~~ was ~~primarily~~ due to ~~favorable pricing related to calendar year 2018 and 2019 customer agreements and~~ the ~~passthrough~~pass-through of ~~higher~~lower feedstock ~~costs in our pricing.~~prices.

EBIT in Reinforcement Materials decreased ~~by $2~~$77 million in the third quarter of fiscal ~~2019~~2020 compared to the same period of fiscal ~~2018. The decrease was primarily due to~~2019. During the third quarter of fiscal 2020, the segment had 42% lower volumes ($375 million), lower unit margins ($118 million), and ~~the~~an unfavorable impact ~~of inventory comparisons~~from foreign currency translation ($14 million), partially offset by lower fixed costs ($320 million). The lower volumes were primarily due to weaker tire and automotive demand resulting from the impacts of COVID-19. Unit margins were negatively impacted by slower turns of inventory and lower energy center revenue as a result of reduced sales volumes and lower feedstock prices offset by favorable pricing from 2020 tire customer agreements. Lower fixed costs were driven by ~~the weaker~~lower production volumes ~~in Europe~~ and ~~Latin America.~~other cost reduction actions.

EBIT in Reinforcement Materials decreased ~~by $20~~$92 million in the first nine months of fiscal ~~2019~~2020 compared to the same period of fiscal ~~2018.~~2019. The decrease was ~~principally~~ driven by lower volumes ($101 million), lower unit margins ($246 million), ~~lower volumes ($2 million)~~ and ~~the~~an unfavorable impact offrom foreign currency translation ($25 million), which were partially offset by lower fixed costs ($720 million). ~~The lower unit margins~~Lower volumes were primarily due to weaker automotive and tire demand and the ~~weaker pricing environment in China that more than~~impacts from COVID-19. Unit margins were negatively impacted by slower turns of inventory and lower energy center revenue as a result of reduced sales volumes and lower feedstock prices offset ~~the~~by favorable pricing ~~related to calendar year 2019~~from 2020 tire customer agreements. Lower fixed costs were driven by lower production volumes and other cost reduction actions.

Sales and EBIT for Performance Chemicals for the third quarter and first nine months of fiscal ~~2019~~2020 and ~~fiscal 2018~~2019 were as follows:

	Three Months Ended June 30				Nine Months Ended June 30				Three Months Ended June 30				Nine Months Ended June 30
	2019		2018		2019		2018		2020		2019		2020		2019
	(In millions)								(In millions)
Performance Additives Sales	$	172	$	188	$	518	$	524	$	151	$	172	$	489	$	518
Formulated Solutions Sales		79		86		218		247		69		79		218		218
Performance Chemicals Sales	$	251	$	274	$	736	$	771	$	220	$	251	$	707	$	736
Performance Chemicals EBIT	$	37	$	56	$	111	$	160	$	21	$	37	$	93	$	111

Sales in Performance Chemicals decreased by ~~$23~~$31 million in the third quarter of fiscal ~~2019~~2020 compared to the same period of fiscal ~~2018,~~2019, primarily due to a less favorable price and product mix (combined $15 million), lower volumes ($1312 million), and the unfavorable impact from foreign currency translation ($4 million). The less favorable price and product mix was primarily due to a more competitive pricing environment and weaker product mix in the fumed metal oxides product line in China and Europe and weaker product mix in our specialty carbons product line from lower demand in automotive applications. The lower volumes were driven by the specialty carbons and specialty compounds product lines due to lower demand in automotive applications driven by the impact of COVID-19 on demand.

In the first nine months of fiscal 2020, sales in Performance Chemicals decreased $29 million when compared to the same period of fiscal 2019. The decrease was primarily due to a less favorable price and product mix (combined $46 million) and the unfavorable impact from foreign currency translation ($10 million), partially offset by higher volumes ($27 million). The less favorable price and product mix was primarily due to a more competitive pricing environment and weaker product mix in the fumed metal oxides product line in China and Europe and weaker product mix in our specialty carbons product line from lower demand in automotive applications. The higher volumes were primarily due to higher demand in the specialty carbons and specialty compounds product lines in the first two quarters of the fiscal year.

EBIT in Performance Chemicals decreased by $16 million in the third quarter of fiscal 2020 compared to the third quarter of fiscal 2019 primarily due to lower unit margins ($9 million) driven by a more competitive pricing environment and weaker ~~sales from~~product mix in the fumed metal ~~oxide~~oxides product line ~~within~~in China and Europe and lower volumes ($7 million) in the specialty carbons and specialty compounds product lines due to lower demand in automotive applications driven by the impact of COVID-19 on demand.

InChemicals decreased by $18 million in the first nine months of fiscal ~~2019, sales in Performance Chemicals decreased by $35 million~~2020 when compared to the same period of fiscal ~~2018. The decrease was~~2019 primarily due to lower ~~volumes~~unit margins ($3515 million), and the unfavorable impact ~~from foreign currency translation~~of inventory comparisons ($2410 million), partially offset by higher volumes ($10 million). Lower unit margins were due to a more ~~favorable price~~competitive pricing environment and product mix (combined $24 million). Volumes were lower across all product lines within Performance Chemicals with the most significant impact being in the Formulated Solutions business. The favorable price and product mix was driven by the metal oxides product line within Performance Additives.

EBIT in Performance Chemicals decreased by $19 million in the third quarter of fiscal 2019 compared to the third quarter of fiscal 2018 primarily due to lower volumes ($9 million), lower unit margins ($10 million) and the unfavorable impact from foreign currency translation ($2 million). Volumes decreased by 2% in the Performance Additives business and 2% in the Formulated Solutions business. Lower volumes were primarily due to lower volumes from our fumed metal oxide and inkjet product lines. Lower margins were largely driven by a weaker product mix in the fumed metal oxides product line in China and Europe and weaker product mix in our specialty carbons product ~~line.~~

~~EBIT~~line due to lower demand in ~~Performance Chemicals decreased~~automotive applications. The higher volumes were driven by ~~$49 million~~our specialty carbons and specialty compounds product lines due to higher demand in the specialty carbons and specialty compounds product lines in the first ~~nine months~~two quarters of the fiscal ~~2019 when compared to the same period of fiscal 2018 principally due to lower~~year and higher volumes ($20 million), lower unit margins ($17 million), higher fixed costs ($10 million) and the unfavorable impact of foreign currency translation ($4 million). Lower volumes were primarily due to softer automotive productionaligned with new capacity in ~~EMEA and China. Lower margins were largely driven by a weaker product mix and the impact of high cost specialty carbons inventory that moved through~~ our ~~supply chain during the first nine months of 2019. Higher fixed costs are largely related to growth investments for our two new~~ fumed metal oxides ~~plants in China and the U.S.~~product line.

Sales and EBIT for Purification Solutions for the third quarter and first nine months of fiscal ~~2019~~2020 and ~~fiscal 2018~~2019 were as follows:

	Three Months Ended June 30					Nine Months Ended June 30						Three Months Ended June 30				Nine Months Ended June 30
	2019		2018			2019			2018			2020		2019		2020		2019
	(In millions)											(In millions)
Purification Solutions Sales	$	73	$	70		$	210		$	206		$	63	$	73	$	186	$	210
Purification Solutions EBIT	$	1	$	(6	)	$	(1	)	$	(6	)	$	2	$	1	$	3	$	(1	)

Sales in Purification Solutions ~~increased~~decreased by $3$10 million in the third quarter of fiscal ~~2019~~2020 compared to the same period of fiscal ~~2018~~2019 due to ~~a more favorable price and product mix (combined $3 million) and higher~~lower volumes ($315 million), partially offset by improved pricing and a more favorable product mix (combined $5 million). The lower volumes were primarily due to lower sales in mercury removal, other industrial gas and air applications and automotive applications impacted by lower demand due to COVID-19.

Sale in Purification Solutions decreased $24 million in the first nine months of fiscal 2020 when compared to the same period of fiscal 2019 due to lower volumes ($39 million) and the unfavorable impact from foreign currency translation ($32 million), partially offset by improved pricing and a more favorable product mix (combined $17 million). ~~Sales~~The lower volumes were primarily due to lower sales in mercury removal, other industrial gas and air applications and automotive applications impacted by lower demand due to COVID-19.

EBIT in Purification Solutions increased by $1 million in the first quarter of fiscal 2020 compared to the third quarter of fiscal 2019 due to higher unit margins ($3 million), and lower fixed costs ($6 million) as a result of prior year restructuring activities and an insurance recovery of approximately $1 million, partially offset by lower volumes ($8 million). The higher unit margins were primarily due to an improved product mix and higher prices. The lower volumes were primarily due to lower sales in mercury removal, other industrial gas and air applications and automotive applications impacted by lower demand due to COVID-19.

EBIT in Purification Solutions improved by $4 million in the first nine months of fiscal ~~2019~~2020 when compared to the same period of fiscal ~~2018~~2019 due to higher volumes ($5 million) and more favorable price and product mix (combined $5 million) in the specialty and environmental applications, partially offset by the unfavorable impact from foreign currency translation ($6 million).

~~EBIT in Purification Solutions improved by $7 million in the third quarter of fiscal 2019 compared to the third quarter of fiscal 2018 due to higher volumes ($1 million), higher~~ unit margins ($213 million) ~~mainly from improved pricing~~ and, lower fixed costs ($311 million)~~. The lower fixed costs are in part due to the impact~~ as a result of the transformation plan for the business that the Company began implementing earlier in the 2019 fiscal year. EBIT in Purification Solutions improved by $5 million in the first nine months of fiscal 2019 when compared to the same period of fiscal 2018 due to higher volumes ($2 million), lower fixed costs ($4 million) due in part to the impact of the transformation plan, the favorable impact of inventory change ($1 million) and the favorable impact of foreign currency translation ($1 million),prior year restructuring activities, partially offset by lower ~~unit margins~~volumes ($420 million). The ~~lower~~higher unit margins ~~for the first nine months of fiscal 2019~~ were primarily due to ~~ongoing competitive pressures within North America lignite powder-based~~an improved product mix and higher prices while the lower volumes were primarily due to lower sales in mercury removal, other industrial gas and air ~~applications.~~applications and automotive applications impacted by lower demand due to COVID-19.

We divested our Specialty Fluids business on June 28, 2019. Refer to ~~Note D of~~ our ~~Notes to the Consolidated Financial Statements~~fiscal 2019 10-K filing for further details. Sales and EBIT for Specialty Fluids for the third quarter and first nine months of fiscal ~~2019~~2020 and ~~2018~~2019 were as follows:

	Three Months Ended June 30				Nine Months Ended June 30					Three Months Ended June 30				Nine Months Ended June 30
	2019		2018		2019		2018			2020		2019		2020		2019
	(In millions)									(In millions)
Specialty Fluids Sales	$	13	$	12	$	56	$	24		$	—	$	13	$	—	$	56
Specialty Fluid EBIT	$	2	$	3	$	24	$	(2	)	$	—	$	2	$	—	$	24

Sales in Specialty Fluids increased by $1 million in the third quarter of fiscal 2019 and $32 million in the first nine months of fiscal 2019 compared to the same periods of fiscal 2018 primarily due to higher volumes from increased project activity.

EBIT in Specialty Fluids decreased by $1 million in the third quarter of fiscal 2019 due to the mix of project activity compared to the same period of fiscal 2018 and increased $26 million in the first nine months of fiscal 2019 compared to the same periods of fiscal 2018 primarily due to higher volumes from increased project activity.

We are not expecting a resolution to the U.S.-China trade dispute and we anticipate automotive production to continue to be weak in the fourth quarter of fiscal 2019. Both of these factors will continue to have a negative impact on our Reinforcement Materials and Performance Chemicals businesses. However, we anticipate the Company’s results in the fourth fiscal quarter to reflect benefits from favorable pricing terms and product mix related to our 2019 tire customer arrangements, higher volumes in our fumed silica business from the start-up of operations at our new plant in Wuhai, China and the timing of off-take from our fenceline partners, lower costs in our Purification Solutions business as we continue to implement the transformation plan for that business, and countermeasures we are taking to manage our costs.

Our liquidity position, as measured by cash and cash equivalents plus borrowing availability, ~~increased~~decreased by ~~$489~~$97 million during the first nine months of fiscal ~~2019,~~2020, which was largely attributable to capital expenditures, the ~~repayment~~acquisition of commercial paper through the proceeds from the sale of the Specialty Fluids business and the issuance of long-term debt, and increased borrowing availability under a new revolving credit agreement, partially offset by higher net working capital,Shenzhen Sanshun Nano New Materials Co., Ltd (“SUSN”), share repurchases and cash dividends, ~~and the redemption of the preferred stock issued in the NHUMO, S.A. de C.V. (“NHUMO”) transaction.~~partially offset by lower net working capital. As of June 30, ~~2019,~~2020, we had cash and cash equivalents of ~~$147~~$162 million and borrowing availability under our revolving credit agreements of ~~$1,278 million. Our U.S. revolving~~$1.2 billion.

At our ~~commercial paper program. Our non-U.S. revolving~~election, loans under the Credit Agreements bear interest at LIBOR plus an applicable margin of between 0.68% and 1.20%, depending on our credit ~~agreements may be used~~ratings, or at the prime rate plus an applicable margin of between 0.00% and 0.20%, depending on our credit ratings, and at similar applicable rates for ~~repatriation~~foreign currency borrowings.

As of earnings of our foreign subsidiaries to the U.S., the repayment of indebtedness of our foreign subsidiaries owing to us or any of our subsidiaries, and for working capital and general corporate purposes.

At June 30, ~~2019,~~2020, we were in compliance with ~~all~~our debt covenants under ~~our revolving credit facilities, including~~ the Credit Agreements, which, with limited exceptions, generally require us to comply on a quarterly basis with a leverage test requiring consolidated total ~~consolidated~~ debt not to exceed consolidated EBITDA (earnings before interest, taxes, depreciation and amortization) ~~covenant.~~for the four quarters then ending by more than 3.50 to 1.00. Because of the uncertainty of the overall financial impact of the COVID-19 pandemic and to increase our financial flexibility, we amended the Credit Agreements as of June 8, 2020 to, among other things: (a) set the consolidated total debt to consolidated EBITDA ratio at 4.50 to 1.00 for the fiscal quarters ending September 30, 2020 through June 30, 2021, and (b) reduce the lien basket for other permitted liens securing Indebtedness (as defined in the Credit Agreements) in an aggregate amount at any time outstanding to 5% of Consolidated Tangible Net Worth (as defined in the Credit Agreements), at any time through and including June 30, 2021. As part of these amendments, we agreed to pay a 10 basis point fee on the consenting lenders’ commitments under the JPM Credit Agreement and the Euro Credit Agreement.

A significant portion of our business occurs outside the U.S. and our cash generation does not always align geographically with our cash needs. The vast majority of our cash and cash equivalent holdings tend to be held outside the U.S. Cash held by foreign subsidiaries is generally used to finance the subsidiaries’ operational activities and future investments. We ~~use~~typically issue commercial paper throughout the year to manage our short-term U.S. cash needs. ~~The~~During the second quarter of fiscal 2020, one of our short-term credit ratings was downgraded, which temporarily decreased our access to, and increased our cost to borrow through, the commercial paper market, and we instead borrowed under our revolving credit agreements. During the third quarter of fiscal 2020, the commercial paper market stabilized and we are currently using a combination of commercial paper and revolving credit facility borrowings to meet our U.S. cash needs. We generally reduce our commercial paper balance ~~is generally reduced~~and, if applicable, borrowings under the Credit Agreements, at quarter-end using cash derived from customer collections, settlement of intercompany balances and short-term intercompany loans. ~~The balance of commercial paper outstanding as of June 30, 2019 was $73 million.~~ In the ~~unusual~~ event that additional funds are needed in the U.S., we ~~have the ability~~expect to be able to repatriate funds or to access additional ~~funds.~~debt under our revolving credit facilities. As of June 30, 2020, our borrowings on the JPM Credit Agreement totaled $75 million, and we had $13 million of commercial paper outstanding. As of June 30, 2020, our borrowings under the Euro Credit Agreement totaled $144 million, and there were no borrowings outstanding under the Canadian Credit Agreement.

We generally manage our cash and debt on a global basis to provide for working capital requirements as needed by region or site. Cash and debt are generally denominated in the local currency of the subsidiary holding the assets or liabilities, except where there are operational cash flow reasons to hold non-functional currency or debt.

WeIn light of the uncertain economic environment created by the COVID-19 pandemic, among other actions we have taken to preserve our liquidity position, we have deferred capital spending where possible and delayed spending on some of our growth projects. With these decisions, we currently expect our capital expenditures for fiscal 2020 to be approximately $200 million in the aggregate to be used primarily for sustaining and compliance capital projects at our operating facilities as well as for growth projects in Performance Chemicals. In addition, during the second quarter of fiscal 2020, we suspended our share repurchase activity, and we do not anticipate repurchasing our shares for the remainder of fiscal 2020.

Although we cannot predict the duration or scope of the COVID-19 pandemic and its impact on our customers and suppliers, we are actively managing the business to maintain cash flow and we anticipate sufficient liquidity from (i) cash on hand; (ii) cash flows from operating activities; and (iii) cash available from our revolving credit ~~agreements and our commercial paper program~~facilities to meet our operational and capital investment needs and financial obligations for the foreseeable future. The liquidity we derive from cash flows from operations is, to a large degree, predicated on our ability to collect our receivables in a timely manner, the cost of our raw materials, and our ability to manage inventory levels.

In June 2019, we issued $300 million in registered notes with a coupon of 4% that mature on July 1, 2029. These notes are unsecured and pay interest on January 1 and July 1 commencing in 2020. The net proceeds of this offering were $296 million after deducting discounts and issuance costs.

~~We issued $30 million of 7.42% medium term notes in fiscal 1999 that matured on December 11, 2018. We repaid these notes at maturity with a combination of cash on hand and commercial paper borrowings.~~

In November 2013, we purchased all of our joint venture partner’s common stock in the former NHUMO joint venture. At the close of the transaction, NHUMO issued redeemable preferred stock to the joint venture partner with a repurchase value of $25 million and a fixed dividend rate of 6% per annum. In November 2018, the preferred stock was repurchased for $25 million and a final dividend payment of approximately $1.4 million was made.

The following discussion of the changes in our cash balance refers to the various sections of our Consolidated Statements of Cash Flows.

Cash provided by operating activities, which consists of net income adjusted for the various non-cash items included in income, changes in working capital and changes in certain other balance sheet accounts, totaled ~~$166~~$278 million in the first nine months of fiscal ~~2019~~2020 compared to ~~$143~~$166 million of cash provided by operating activities during the same period of fiscal ~~2018.~~2019.

Cash provided by operating activities in the first nine months of fiscal 2020 was driven primarily by our net income of $44 million, a decrease in Accounts and notes receivable of $172 million, the non-cash impact of depreciation and amortization of $117 million and a decrease in our Inventories of $74 million, partially offset by a decrease in Accounts payable and accrued liabilities of $68 million, an increase in Prepaid expenses and other assets of $25 million and the non-cash impact of a deferred tax benefit of $20 million.

Cash provided by operating activities in the first nine months of fiscal 2019 was driven primarily by our net income of $146 million, the non-cash impacts of depreciation and amortization of $110 million, ~~and~~ the loss on the sale of the Specialty Fluids business of $28 million and the impairment of our investment in our Venezuelan equity affiliate of $11 million. Partially offsetting these factors were a decrease in Accounts payable and accrued liabilities of $65 million, a decrease in Income taxes payable of $24 million, a decrease in Other liabilities of $27 million and the non-cash impact of a ~~decrease in our~~ deferred tax ~~provision~~benefit of $20 million.

Cash provided by operating activities in the first nine months of fiscal 2018 resulted primarily from a net loss of $176 million and the non-cash impacts of the impairment of the assets and goodwill of the Purification Solutions business of $162 million and $92 million, respectively, depreciation and amortization of $117 million and an increase in our deferred tax provision of $131 million. In addition, there was an increase in Accounts payable and accrued liabilities of $40 million. Partially offsetting these factors were increases in Accounts and notes receivable and Inventories of $151 million and $77 million, respectively.

In addition to the factors noted above, the following other elements of operations have a bearing on operating cash flows:

Restructurings — As of June 30, ~~2019,~~2020, we had ~~$12~~$9 million of total restructuring costs in accrued expenses in the Consolidated Balance Sheets related to certain of our global restructuring activities. In the ~~remainder~~first nine months of fiscal ~~2019 and thereafter,~~2020, we ~~expect to make cash payments totaling approximately~~paid $13 million related to these restructuring ~~plans.~~activities, and we expect to make additional cash payments of approximately $4 million in fiscal 2020 and $11 million thereafter.

~~Environmental Reserves and Litigation~~Legal Matters — As of June 30, 2019 and September 30, 2018, we had a $14 million and $15 million reserve, respectively, for environmental remediation costs at various sites. These sites are primarily associated with businesses divested in prior years. Additionally, as of June 30, 2019 and September 30, 2018,2020, we had a $21 million reserve for existing and ~~$25~~future respirator claims that we expect to pay over multiple years. During the second quarter of fiscal 2020, we settled a large group of respirator claims for $65.2 million. We paid $32.6 million ~~reserve, respectively, for respirator claims. As of June 30, 2019, we had committed to payments~~ related to these settled claims during the third quarter of $9fiscal 2020, and the remaining $32.6 million ~~$4 million~~payable will be paid in the first quarter of ~~which has been paid through June 30, 2019.~~fiscal 2021. We also have other ~~litigation costs~~lawsuits, claims and contingent liabilities arising in the ordinary course of business.

Investing activities consumed $252 million of cash in the first nine months of fiscal 2020 compared to $33 million of cash consumed during the same period of fiscal 2019. In the first nine months of fiscal 2020, investing activities primarily consisted of $162 million of capital expenditures for sustaining and compliance capital projects at our operating facilities as well as capacity expansion capital expenditures in Reinforcement Materials and Performance Chemicals, $84 million, net of cash acquired for the SUSN acquisition in April 2020 and $8 million for the plant that we acquired from NSCC in September 2018.

In the nine months ended June 30, 2019, investing activities consumed $33 million of cash, which was primarily driven by $155 million of capital expenditures ~~of $155 million,~~for sustaining and compliance capital projects at our operating facilities as well as capacity expansion capital expenditures in Reinforcement Materials and Performance Chemicals, partially offset by proceeds from the sale of the Specialty Fluids business of $130 million, net of cash held in escrow of $5 million. These capital expenditures were for sustaining and compliance capital projects at our operating facilities as well as capacity expansion capital expenditures in Reinforcement Materials and Performance Chemicals. In the nine months ended June 30, 2018, investing activities consumed $211 million of cash, which was primarily driven by $64 million of cash paid for our acquisition of Tech Blend, net of cash acquired of $1 million, and capital expenditures of $167 million. These capital expenditures were for sustaining and compliance capital projects at our operating facilities as well as expansion capital expenditures.

Capital expenditures for fiscal 2019 are expected to be between $230 million and $240 million. Our planned capital spending program for fiscal 2019 is primarily for sustaining, compliance and improvement capital projects at our operating facilities as well as expansion capital expenditures in Reinforcement Materials and Performance Chemicals.

Financing activities consumed ~~$146~~$37 million of cash in the first nine months of fiscal ~~2019~~2020 compared to ~~$69~~$146 million of cash consumed induring the same period of fiscal 2019. In the first nine months of fiscal ~~2018.~~ 2020, financing activities primarily consisted of the repayment of $15 million of other long-term debt, share repurchases of $44 million, dividend payments to stockholders of $60 million, dividend payments to noncontrolling interests of $26 million and the repayment of $20 million of commercial paper, partially offset by the net proceeds from borrowings under our revolvers of $125 million.

In the first nine months of fiscal 2019, financing activities primarily consisted of share repurchases of $144 million, dividend payments to stockholders of $60 million, the repayment of $75 million of long-term debt, the repayment of $176 million of commercial paper, and the redemption of $25 million of preferred stock held by our former NHUMO joint venture partner, partially offset by the proceeds from the issuance of our registered notes and borrowing under our European revolver in the aggregate of $344 million.

In the first nine months of fiscal 2018, financing activities consisted of share repurchases and dividend payments to stockholders as well as the repayment of our $250 million of 2.55% fixed rate debt, which was offset by proceeds from the issuance of commercial paper.

We have entered into long-term purchase agreements primarily for the purchase of raw materials. Under certain of these agreements the quantity of material being purchased is fixed, but the price paid changes as market prices change. For those commitments, the amounts included in the table below are based on market prices at June 30, 2019, which may differ from actual market prices at the time of purchase.

As of June 30, ~~2019,~~2020, we had no material transactions that meet the definition of an off-balance sheet arrangement.

This report on Form 10-Q contains “forward-looking statements” under the Federal securities laws. These forward-looking statements address expectations or projections about the future, including our expectations for future financial performance and the factors we expect to impact our ~~volumes,~~results of operations, including how we expect the COVID-19 pandemic to impact demand for our products, ~~costs~~our results of operations and ~~margins;~~our cash flows and our related mitigation efforts; growth in the battery market; when we expect the ~~purchase price for our purchase of~~ NSCC Carbon ~~to be payable and the~~plant upgrades ~~of that plant~~ to be completed; the amount and the timing of the contingent consideration we expect to pay related to the SUSN acquisition; the amount and timing of the charge to earnings we will record and the cash outlays we will make in connection with our reorganization and the closing of certain manufacturing facilities, restructuring initiatives and under our transformation plan for our Purification Solutions business; our estimated future amortization expenses for our intangible assets; when we expect to make payments under the settlement agreement we entered into settling certain respirator liability claims; the timing of expected payments from our reserve for existing and future respirator claims; the amount of any future gain or loss we may record upon the settlement, and the timing of the completion, of certain defined benefit obligations and pension plan ~~assets we transferred to a multi-employer plan;~~terminations; the sufficiency of our cash on hand, cash provided from operations and cash available under our credit facilities to fund our cash requirements; uses of available cash including anticipated capital spending, share repurchases, and future cash outlays associated with long-term contractual obligations; our expected tax rate for fiscal ~~2019;~~2020; and the possible outcome of legal ~~and environmental~~ proceedings. From time to time, we also provide forward-looking statements in other materials we release to the public and in oral statements made by authorized officers.

Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, potentially inaccurate assumptions, and other factors, some of which are beyond our control or difficult to predict. If known or unknown risks materialize, our actual results could differ materially from those expressed in the forward-looking statements. Importantly, as we cannot predict the duration or scope of the COVID-19 pandemic, the negative impact to our results cannot be estimated. Factors that will influence the impact on our business and operations include the duration and extent of the pandemic, the extent of imposed or recommended containment and mitigation measures, and the general economic consequences of the pandemic.

In addition to factors described elsewhere in this report, the following are some of the factors that could cause our actual results to differ materially from those expressed in ~~the~~our forward-looking statements: changes in raw material costs; lower than expected demand for our products; changes in environmental requirements in the U.S.; the loss of one or more of our important customers; our inability to complete capacity expansions or other development projects; the availability of raw materials; our failure to develop new products or to keep pace with technological developments; fluctuations in currency exchange rates; patent rights of others; stock and credit market conditions; the timely commercialization of products under development (which may be disrupted or delayed by technical difficulties, market acceptance, competitors’ new products, as well as difficulties in moving from the experimental stage to the production stage); demand for our customers’ products; competitors’ reactions to market conditions; unanticipated disruptions or delays in plant operations or development projects; delays in the successful integration of structural changes, including acquisitions or joint ventures; severe weather events that cause business interruptions, including plant and power outages or disruptions in supplier or customer operations; ~~changes in~~negative or uncertain worldwide or regional economic conditions and market opportunities, including from trade relations or global ~~trade policies;~~health matters; the accuracy of the assumptions we used in establishing reserves for environmental matters and for our share of liability for respirator claims; and the outcome of pending litigation. ~~Other~~These other factors and risks are discussed more fully in our ~~2018 10-K.~~2019 10-K, our Quarterly Report for the quarterly period ended March 31, 2020 and in our subsequent SEC filings.

Information about market risks for the period ended June 30, ~~2019~~2020 does not differ materially from that discussed under Item 7A of our ~~2018~~2019 10-K.

As of June 30, ~~2019,~~2020, we carried out an evaluation, under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, of the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended. Based upon that evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective as of that date.

There were no changes in our internal control over financial reporting that occurred during our fiscal quarter ended June 30, ~~2019~~2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

As a result of the COVID-19 pandemic, certain of our employees have been working remotely and certain manufacturing sites have been operating with limited personnel on-site. We have not identified any material changes in our internal control over financial reporting as a result of these changes to the working environment. We are continually monitoring and assessing the COVID-19 situation to determine any potential impacts on the design and operating effectiveness of our internal controls over financial reporting.

~~The table below sets forth information regarding Cabot’s purchases of its equity securities during the quarter ended June 30, 2019:~~

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, $1 par value per share	CBT	The New York Stock Exchange


Large accelerated filer	☒	Accelerated filer	☐

Non-accelerated filer	☐☐	Smaller reporting company	☐

Emerging growth company	☐

Part I.	Financial Information

	Item 1.	Financial Statements (unaudited)
		Consolidated Statements of Operations	3
		Consolidated Statements of Comprehensive Income (Loss)	4
		Consolidated Balance Sheets	5
		Consolidated Statements of Cash Flows	7
		Consolidated Statements of Changes in Stockholders’ Equity	8
		Notes to the Consolidated Financial Statements	10

	Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	3230
	Item 3.	Quantitative and Qualitative Disclosures About Market Risk	4442
	Item 4.	Controls and Procedures	4442

Part II.	Other Information
	Item 2.	~~Unregistered Sales of Equity Securities and Use of Proceeds~~	45
	~~Item~~ 6.	Exhibits	4643

Description	June 30, 2020
Weighted-average remaining lease term (years):
Operating leases		16
Finance leases		12
Weighted-average discount rate:
Operating leases		2.21	%
Finance leases		4.44	%

		Notional Amount
Description	Borrowing	June 30, ~~2019~~2020	September 30, ~~2018~~2019	Hedge Designation
Cross-Currency Swaps	3.4% Notes	USD 250 million swapped to EUR 223 million	USD 250 million swapped to EUR 223 million	Net investment
Forward Foreign Currency Contracts ⁽¹⁾	N/A	USD 2832 million	USD 1854 million	No designation


☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

	(In millions)
Assets
Cash	$	1
Accounts Receivable		8
Inventories		4
Prepaid expenses and other current assets		2
Property, plant and equipment		38
Intangible assets		15
Goodwill		45
Deferred tax asset		1
Other assets		2
Total assets acquired		116

Liabilities
Accounts payable and accrued liabilities		(12	)
Income taxes payable		(2	)
Long-term debt		(13	)
Other liabilities		(4	)

Total liabilities assumed		(31	)

Cash consideration paid	$	85

	Three Months Ended March 31, 2018
	(In millions)
Purification Solutions goodwill impairment charge	$	92
Purification Solutions long-lived assets impairment charge		162
Benefit for income taxes		(30	)
Impairment charges, after tax	$	224

	Payments Due by Fiscal Year
	Remainder of Fiscal 2019		2020		2021		2022		2023		Thereafter		Total
	(In millions)
Reinforcement Materials	$	100	$	251	$	139	$	131	$	123	$	1,584	$	2,328
Performance Chemicals		27		63		59		57		34		510		750
Purification Solutions		1		6		1		—		—		—		8
Total	$	128	$	320	$	199	$	188	$	157	$	2,094	$	3,086

Description	Balance Sheet Classification	June 30, 2020
		(In millions)
Lease ROU assets:
Operating	Other assets	$	102
Finance	Net property, plant and equipment		45
Total lease ROU assets		$	147

Lease liabilities:
Current:
Operating	Accounts payable and accrued liabilities	$	17
Finance	Current portion of long-term debt		3
Long-term:
Operating	Other liabilities		91
Finance	Long-term debt		28
Total lease liabilities		$	139

Years Ended September 30	Operating leases		Finance leases
	(In millions)
Remainder of fiscal 2020	$	6	$	1
2021		16		5
2022		12		4
2023		10		4
2024		10		4
2025 and thereafter		75		25
Total lease payments		129		43
Less: imputed interest		21		12
Total	$	108	$	31

Years Ended September 30	Operating leases		Capital leases
	(In millions)
2020	$	23	$	3
2021		14		3
2022		9		3
2023		9		3
2024		8		2
2025 and thereafter		68		7
Total lease payments		131		21
Less: imputed interest		—		9
Total	$	131	$	12

Level 1	—	Quoted market prices in active markets for identical assets or liabilities

Level 2	—	Significant other observable inputs (e.g., quoted prices for similar items in active markets, quoted prices for identical or similar items in markets that are not active, inputs other than quoted prices that are observable such as interest rate and yield curves, and market-corroborated inputs)

Level 3	—	Significant unobservable inputs

	~~Forecast for the Year Ended September 30, 2019~~
~~Effective tax rate~~		23	%
~~Impact of discrete tax items:~~
~~Unusual or infrequent items~~		2	%
~~Items related to uncertain tax positions~~		1	%
~~Other discrete tax items~~		—	%
~~Impact of certain items~~		(3	)%
~~Operating tax rate~~		23	%

Period	Total Number of Shares Purchased⁽¹⁾⁽²⁾		Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs⁽¹⁾		Maximum Number (or Approximate Dollar Value) of Shares that May Yet Be Purchased Under the Plans or Programs⁽¹⁾
April 1, 2019 - April 30, 2019		—	$	—		—		7,348,345
May 1, 2019 - May 31, 2019		350,000	$	41.93		350,000		6,998,345
June 1, 2019 - June 30, 2019		393,300	$	45.19		393,300		6,605,045
Total		743,300				743,300

Exhibit No.		Description

Exhibit 3.1		Restated Certificate of Incorporation of Cabot Corporation effective January 9, 2009 (incorporated herein by reference to Exhibit 3.1 of Cabot’s Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2008, file reference 1-5667, filed with the SEC on February 9, 2009).

Exhibit 3.2		The By-laws of Cabot Corporation as amended January 8, 2016 (incorporated herein by reference to Exhibit 3.1 of Cabot Corporation’s Quarterly Report on Form 10-Q for the quarterly period ended December 31, 2015, file reference 1-5667, filed with the SEC on February 5, 2016).

Exhibit ~~10.1~~10.1*		First Amendment, dated June 8, 2020, to Credit Agreement dated October 23, 2015 among Cabot Corporation, JPMorgan Chase Bank, N.A., J.P. Morgan Securities LLC, Citigroup Global Markets Inc., Citibank, N.A., Bank of America, N.A., Mizuho Bank, Ltd., TD Bank, N.A., and Wells Fargo Bank, National Association, and the other lenders party thereto.
Exhibit 10.2*		First Amendment, dated June 8, 2020,to Credit Agreement dated May 22, 2019 among Cabot Corporation, certain subsidiaries of Cabot, ~~Corporation,~~ the lenders referred to therein, Wells Fargo Bank, National Association, Wells Fargo Securities, LLV, PNC Bank, National Association, U.S. Bank National Association and Mizuho Bank, Ltd. ~~(incorporated herein by reference to Exhibit 10.1 of Cabot Corporation’s Current Report on Form 8-K dated May 28, 2019, file reference 1-5667, filed with the SEC on May 29, 2019)~~.

Exhibit 31.1*		Certification of Principal Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.

Exhibit 31.2*		Certification of Principal Financial Officer required by Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act.

Exhibit 32**		Certifications of the Principal Executive Officer and the Principal Financial Officer pursuant to 18 U.S.C. Section 1350.

Exhibit 101.INS*		Inline XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

Exhibit 101.SCH*		Inline XBRL Taxonomy Extension Schema Document.

Exhibit 101.CAL*		Inline XBRL Taxonomy Extension Calculation Linkbase Document.

Exhibit 101.DEF*		Inline XBRL Taxonomy Extension Definition Linkbase Document.

Exhibit 101.LAB*		Inline XBRL Taxonomy Extension Label Linkbase Document.

Exhibit 101.PRE*		Inline XBRL Taxonomy Extension Presentation Linkbase Document.

Exhibit 104*		The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, ~~2019,~~2020, formatted in Inline XBRL (included in Exhibit 101).

	CABOT CORPORATION

Date: August ~~8, 2019~~7, 2020	By:	/s/ Erica McLaughlin
		Erica McLaughlin
		Senior Vice President and Chief Financial Officer
		(Duly Authorized Officer)


Date: August ~~8, 2019~~7, 2020	By:	/s/ J~~ames~~ ~~P. Kelly~~Lisa m. Dumont
		~~James P. Kelly~~Lisa M. Dumont
		Vice President and Controller (Chief Accounting Officer)